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Abstract
This study explores the utility o f mass spectrometry for the characterisation o f DNA
constituents.
The tandem mass spectra (MS/MS) following electrospray ionisation (ESI) o f
nucleotides (from 2-12 mers) were examined under a range o f collision and
ionisation conditions.

In general, abundant peaks due to the free bases and

phosphate groups were observed along with a limited number o f sequence ions. A
number o f strategies for increasing the extent o f the observed fragmentation were
investigated. Increasing the skimmer potential, and thereby increasing the initial
internal energy o f the incident ions, did not significantly enhance the sequencespecific fragmentation, although the relative intensities o f fragment ions increased.
In the ESI-MS/MS spectra of different adducts (i.e. [M+H]+, [M-H]') o f
dinucleotides, the intensity o f the ions due to the bases (BH2+ or B') is dependent on
both the base position and the nature o f the adduct ion. These data show that the
MS/MS spectra o f [M-H]' ions o f dinucleotides generated by ESI may provide as
much structural information as the MS/MS spectra obtained following fast atom
bombardment. With [M+Li]+ ions, more sequence ions were observed compared to
the corresponding protonated and deprotonated species.

For oligonucleotide

hexamers, MS/MS spectra o f the [M-2H]2' ions show fragment ions due to the loss o f
bases followed by cleavage o f the 3 ' C-0 bond in the sugar from which the base is
lost (i.e. w ions); however, a strong preference for loss o f any particular base is not
observed. Finally, MS/MS spectra o f 5 -ApCpC-3 , 5 -d(AGGCCT)-3

and

5'-d(CCGTAATTACGG)-3r obtained on a magnetic sector orthogonal acceleration
time-of-flight mass spectrometer demonstrate the potential utility of this instrumental
configuration for MS/MS analysis o f oligonucleotides.
The reaction between the antitumour agent pyrindamycin A (PyA) and the
oligonucleotides 5'-CGGTAATTACCG-3' and 5’-CGCGAATTCGCG-3' was studied
by HPLC and ESI-MS.

Pyrindamycin A is a minor groove binding agent that

alkylates the N3 position of adenine.

A range of experimental conditions were

examined where the pH, reaction time and the reaction buffer were varied.
IV

Formation o f the PyA adduct o f the oligonucleotide was optimised when the reaction
was buffered to pH 8.0 with sodium phosphate for 11 days.

During HPLC

purification o f the reaction mixture, two peaks were generally observed due to the
unreacted oligonucleotide and the adduct respectively. ESI-MS spectra o f the adduct
showed the presence o f two different species, namely the oligonucleotide less base A
and the [(PyA-HCl)+A]' adduct. These were thought to be decomposition products
o f the PyA adduct o f the oligonucleotide occurring during the ESI process. This
suggests that the adducts o f pyrindamycin A are more labile than adducts formed
between other alkylating agents such as those that alkylate guanine (for which it has
been shown that intact adducts can be observed).

While only one adduct was

observed for the 5'-CGGTAATTACCG-3' sequence based on the HPLC profiles, two
adducts were evident for 5'-CGCGAATTCGCG-3'. This is thought to arise because
the first oligonucleotide has a highly preferred binding site at A9, whereas in the
second sequence no adenines are contained within a preferred binding site and the
binding is therefore less specific.
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1. Introduction
Deoxyribonucleic acid (DNA) is a polynucleotide which serves as the carrier for genetic
information.

The

primary structure of DNA is

a specific sequence of

deoxyribonucleotides. These deoxyribonucleotides are comprised of a base, a sugar
moiety, and a phosphate group. The base of the DNA is responsible for carrying the
genetic information, while the sugar and phosphate groups perform a structural role.
There are four different bases, each of which can exist in a different tautomeric form.
They are adenine (A), thymine (T), guanine (G) and cytosine (C), and their predominant
tautomeric forms are shown in Figure 1.1. (1)

guanine

cytosine

Figure 1.1: Structures of the DNA bases
The secondary structure of DNA is normally a double helix, which is also referred to as
a duplex. The two sequence strands are held together through hydrogen bonding of the
base pairs A:T and G:C.(1) The difficulty of using DNA as a target for drug interactions
stem from its biological role and the risk of disrupting a normal function. For this
1

reason only serious diseases, such as cancer, have been treated with drugs that interact
with nucleic acids. The development of more effective, less toxic, antitumour agents
require that the techniques utilised for assessing the binding of the ligand to DNA
become very specific.(2) Techniques such as nuclear magnetic resonance spectroscopy
(NMR) and x-ray crystallography have previously been used for the characterisation of
ligand-DNA interactions, however, large amounts of sample are required for these
analyses. For this reason mass spectrometry is rapidly becoming an established tool for
the analysis of drug-DNA interactions since only very low concentrations of sample (in
the order of pmol/pL) are required. Mass spectrometry can be used to determine the
molecular weight of the ligand-DNA complexes, and tandem mass spectrometry
(MS/MS) experiments can provide structural information.

1.1. Mass Spectrometry Instrumentation
Mass spectrometry is a technique that is used to determine the molecular weight of a
molecule. A mass spectrometer is normally comprised of an ionisation source, in which
ions are introduced into the gas phase; a mass analyser, which is responsible for
separating the ions according to their mass-to-charge ratio or velocity; and a detector and
computer data system, by which the data is recorded and processed. In addition, samples
must be analysed under high vacuum. Many different molecules have been analysed by
mass spectrometry, including peptides, proteins, oligonucleotides, sugars and low
molecular weight organic and inorganic compounds.

1.1.1. Ionisation Techniques
The method by which molecules are ionised for mass spectrometry depends on the
volatility of the sample to be analysed. Electron ionisation (El) and chemical ionisation
(Cl) are the commonly used ionisation techniques for volatile compounds. With El,
ionisation occurs when organic molecules in the gas phase are bombarded by energetic
electrons. In Cl, the molecules are ionised by ion-molecule reactions with a positively or
negatively charged reagent ion that may itself be formed as a result of El or subsequent
ion-molecule reactions.(3)

2

Techniques with the capability for ionisation of thermally labile involatile compounds
have been under development for nearly thirty years. Fast-atom bombardment (FAB),
plasma desorption (PD), matrix-assisted laser desorption/ionisation (MALDI), field
desorption (FD), electrospray ionisation (ESI), thermospray (TS) and aerospray (AS) are
techniques that have been developed during this period for the ionisation of involatile
compounds.

All of these techniques are commonly referred to as ‘soft’ ionisation

techniques. This means that they are capable of producing at least some intact ions of
the involatile parent species after ionisation.(4)
Early techniques for the ionisation of involatile compounds were not suitable for the
analysis of long sequences of oligonucleotides. FD was introduced in 1969 but never
became widely used because it was technically very difficult to implement. In the mid
1970’s PD was a favoured technique but it was mainly used for proteins and generally
had poor resolution. In 1981, the introduction of FAB initiated the widespread use of
mass spectrometry for biomolecules but it was still not very successful for the analysis
of DNA, as only strands up to 13 bases could be analysed. The introduction of MALDI
and ESI in the mid to late 1980’s allowed the analysis of oligonucleotides and intact
DNA to be performed routinely for the first time.

1.1.1.a. Matrix-Assisted Laser Desorption / Ionisation (MALDI)
The MALDI technique was developed by Karas and Hillenkamp in 1988, (5)(6) when
they reported the use of MALDI with a UV laser for molecular weight determination of
proteins up to 67 kDa. MALDI was based on the LD (laser desorption) technique(7),
with the introduction of a matrix to reduce the radiation damage observed in LD.
Because of this damage, LD was limited to molecules of up to approximately 1000 Da.
MALDI involves isolating the analyte molecules in an appropriate UV absorbing matrix,
and irradiating the sample with a high intensity pulsed laser beam tuned to an absorption
band of the matrix. Mass analysis of the resulting ions is most often carried out by timeof-flight mass spectrometry.(8)(9)
MALDI has been used in the analysis of a wide range of biomolecules where it has the
advantage of high sensitivity (pmol) and rapid routine analysis.

3

l.l.l.b . Electrospray Ionisation (ESI)
Electrospray was developed in 1968 by Dole and coworkers who published their report
on “Molecular Beams of Macroions”(10) in which they concluded that the electrospray
technique could be used to produce distinct macroions of defined mass-to-charge ratio
(m/z) in the gas phase.

These macroions were detected in a Faraday cage, after

concentration in a supersonic jet (with energy analysis for mass determination). Despite
some errors in the assumptions made by Dole, several groups including that of Fenn,
used the basic principles of the study as a starting point for the continued study and
development of the electrospray technique.(4) Fenn conducted the majority of early
electrospray studies(4)( 11-14) and obtained results similar to Dole, but could not solve
two major experimental problems, namely:
i. the retarding potential method used for estimating m/z was unsatisfactory for
determining the mass of very large ions, and no alternatives were readily available;
ii. the gains that electron multipliers normally provide were denied because large
macroions did not produce secondary electrons when they struck the first dynode of
the multiplier.
Due to these difficulties, Fenn abandoned work on macroion beams for a number of
years. His interest was later rekindled as a potential means of introducing complex,
relatively involatile molecules into the gas-phase for infrared spectroscopic studies
without decomposition.(11) These new ESI studies analysed low molecular weight
solute species so a quadrupole mass filter could be employed for mass analysis.
Arginine and polyethylene glycol (PEG), with an average molecular weight in the range
200-17500 Da were two of the first involatile solutes that Fenn examined by ESI.
(13)(14)
There are several different electrospray sources in common use. Figure 1.2 shows a
schematic diagram of the electrospray source on one of the instruments used in this
study.

4

Source Vacuum

Analyser Vacuum
3 x 10"6 mb

Analyte

Lens Stack

Figure 1.2: Electrospray Ionisation Source
Each different source invokes different ion optics and / or desolvation methods, however
the mechanism for ion formation is fundamentally the same as that used by Fenn and
coworkers. Fenn used the model displayed in Figure 1.3a to describe the mechanism of
ESI, which was based on the mechanism proposed originally by Iribame and
Thompson(15). The solution is passed through a capillary at a potential of several
kilovolts relative to the surrounding chamber walls, thus depositing charge onto the
surface of the emerging liquid. The consequent coloumbic forces are sufficient to
overcome the surface tension so that the liquid is dispersed in a fine spray of charged
droplets. These droplets rapidly evaporate in the bath gas. As the droplets decrease in
size, the increase in surface charge density and the decrease in radius of curvature result
in electric fields sufficiently strong to desorb solute ions. Part of the resulting dispersion
of ions in the bath gas passes through a small orifice into an evacuated region, through
the skimmer orifice, and then finally on to the mass analyser.(l 1)(12)(14)
There are two advantages of spraying into a bath gas instead of a vacuum. The energy of
the ions entering the mass analyser can be more readily controlled using the bath gas, as
it prevents the acceleration of ions to corresponding high energies. It also stops the
fouling of the high-vacuum portion of the apparatus with nonvolatile solvent material.
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An alternative ESI mechanism was proposed by Rollgen and coworkers( 14), who
favoured a variation to the charged-residue model originally proposed by Dole et al.( 10)
displayed in Figure 1.3b. They found that Fenns’ desorption model did not produce ions
with sufficient velocity to account for the observed ion currents. Their mechanism
proposed that ESI dispersion of a sufficiently dilute solution would produce charged
droplets containing a single solute molecule. This molecule would retain some or all of
the droplet charge as the last of the solvent evaporated. Fenn had disagreed with this
mechanism as it did not seem able to account for the marked effect of cosolutes on the
population of cluster ions in the gas-phase, the studies of which had supported the ion
desorption mechanism(14).
Since 1988, there have been many reports (13)(16-26) discussing the two mechanisms,
however, none have been conclusive and the mechanism of ESI is still the subject of
debate.

Desorption of
charged ion

Coloumbic explosion
\

/

Figure 1.3: a) the ESI ion desorption mechanism b) the ESI charge residue mechanism.
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A mechanism for the production of multiply charged molecular ion species has yet to be
proposed. ESI-MS generally imparts multiple charges to larger analyte molecules. The
extent of this charging increases in near proportion with the molecular weight of the
molecule.(25) Multiple charging generates multiple experimental data points which
improve the mass accuracy and precision of molecular weight measurement.(24) If the
charge states are not known and adjacent peaks differ by a charge of one, the molecular
weight can be determined from the m/z values(23) using the averaging algorithm
described by Equation 1.1 and 1.2.(27)
Equation 1.1:

Ki = (M+ima) = M + ma
i
i

where:
M = Mr = molecular mass of the molecule
i = number of charges
ma = mass of the adduct, if the ions are protonated ma=l
Ki = apparent value of m/z for peak position Ki’ = Ki-ma
therefore, using charge states i and i+j (j>0)
Equation 1.2:

i = j (Xi+i’)
RE-Ki+j’

where Ki and Ki+j are determined directly from the ESI mass spectrum
By rearranging the above equations, M, ma, Ki or Ki+j can also be determined. When
this algorithm is used to determine M a number of values are obtained and then averaged
to give the best estimate of the molecular mass.

Most commercial ESI mass

spectrometers incorporate computer packages that enable these calculations to be readily
performed.
Cation adduction and resolved isotopic peaks can also provide mass and charge
assignment for electrosprayed molecules.(28)

1. 1. 1. b. a. Electrospray of Peptides and Proteins
The majority of early ESI-MS studies concerned peptides and proteins. ESI-MS was
used mainly for sequence confirmation(26) and to detect changes to proteins such as
7

post-translational modifications. Conformational changes in proteins have also been
probed by ESI(29)(30).

Structural information was gained through ESI-MS/MS

studies(26)(31)(32) allowing sequence databases to be established(33), and a common
nomenclature for fragmentation to be developed.(34) It was also shown that when
disulphide bonds were reduced, increased multiple charging was observed, and that a
correlation existed between the maximum positive charge observed in the spectrum and
the number of basic residues in the sequence when no disulphide bonds were
present.(35)

1. 1. 1. b. b. Recent Developments in Electrospray
The most recent ESI-MS development has been that of nano- or micro-electrospray. A
number of different systems have been developed, producing similar results. These
techniques increase the sensitivity of the conventional electrospray source, mainly
through the use of lower solvent flow rates in the nL / min range. The reduced flow
results in smaller droplets being formed, which allows a larger proportion of analyte
molecules to be available for desorption, longer measurement times, and rapid
evaporation of solvent. This allows the tip of the capillary to be positioned closer to the
orifice of the vacuum system, allowing a larger fraction of the ESI generated analyte ions
to be drawn into the analyser with less solvent than in a conventional ESI
source.(36)(37)
Solutions containing up to 0.1 M salt content have been shown to produce spectra
successfully using nano/micro-ESI/MS. This increase in salt tolerance indicates that
spectra can be obtained from near physiological concentrations of buffer.(37)(38)
Nano/micro-ESI/MS has been applied to a range of biological systems. These studies
include:
i. resolution of individual glycoforms of a glycoprotein with the resolution only limited
by the mass analyser(37)
ii. enzymatic C-terminal amino acid sequencing of a 39 kDa protein(37); and
iii. MS/MS of methionine enkephalin from a 500 amol injection.(36)

Nano/micro-ESI/MS has also recently been demonstrated for oligonucleotides and their
8

noncovalent complexes. The ratio of duplex : single stranded DNA was 100 fold greater
for nano/micro-ESI compared to a conventional ESI source.

This may be due to

low-flow rate sources generating less collision-induced dissociation in the transport
region of the source.(3 8)
Reduced detection limits for proteins, in the attomole range, have also been obtained
using capillary electrophoresis (CE) coupled to ESI/MS.(39) The sensitivity of this
technique is greatly improved with the use of smaller internal diameter (i.d.) capillaries.
The efficiency of the process and the solute sensitivity are also increased with decreasing
capillary i.d. The mass spectra obtained for a 600 amol injection of a protein were of
sufficient quality to allow determination of their individual molecular weights to
approximately 0.03%. (3 9)

'

1.1.2. Mass Analysers
Electrospray ionisation can be used with quadrupole, time-of-flight, ion trap, magnetic
sector, and Fourier transform mass analysers, all of which separate ions according to
their mass-to-charge (m/z) ratio. Of these, only the quadrupole and magnetic sector
analysers were used in this study and are described here.

1.1.2.a. Quadrupoles
Quadrupole mass filters are one of the most commonly used mass analysers due to their
relative low cost and ease of use. A typical quadrupole consists of four conductive
parallel rods, symmetrical to the horizontal axis, with the opposite rods being electrically
connected. These rods shape an electrodynamic field which is a combination of radio
frequency (RF) and direct current (DC). The ion trajectories in this field are determined
by the amplitude of the electric field. With the correct amount of RF and DC voltage
applied to the quadrupole, an ion of a particular selected m/z emerges from the opposite
end of the analyser. Ions with other m/z ratios will oscillate further and further from the
axial path until they strike or pass between the rods.

The higher the RF and DC

amplitude the higher the m/z selected, and vice versa. By scanning RF and DC voltages
from zero to their maximum value, ions will be transmitted sequentially in order of their
m/z with a constant m/z window.(7)(40)
9

1.1.2. b. Magnetic Sector
Magnetic sector mass analysers are more expensive than quadrupoles, but have high
mass resolution (when combined with electric sectors) and a generally higher mass
range. Magnetic sector analysers use a magnetic field to separate ions of different m/z
ratios. The ions are accelerated from the source (with energy Vacc) and through the
magnetic field (with field strength B). This combination of magnetic field and the
forward velocity of the ion cause it to follow a curved path. The radius (r) of the curve
is dependent on the m/z ratio of the ion, magnetic field strength and the charge and
initial energy of the ion. For a given field strength, only a single m/z value will curve at
the radius needed to reach the detector. The m/z determination is given in equation 1.3.
Equation 1.3:

m/z = BV / 2Vacc

To overcome the spread in ion energies, double focussing magnetic sector instruments
are used, in which an electrostatic sector is combined with the magnetic sector to give
energy focussing and thus enable higher mass resolution.(7)(40)(41)(42)

1.1.2.

C.

Tandem Mass Spectrometry

Tandem mass spectrometry (MS/MS), has been used for over a decade to gain structural
information on a variety of compounds. As the name suggests there are two stages of
mass analysis. The first is the mass selection of the precursor ion. Nonselected m/z
values are in effect filtered out. The precursor ion then undergoes the reaction:
Mp+ —>Md+ + Mn
where,
Mp+ is the precursor ion mass
Md+ is the product ion mass
Mn is the neutral fragment mass
Before this reaction can occur the activation barrier must be overcome. The energy
required to do so can come from one of two sources:
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i. metastable decomposition, in which excess energy is deposited on the precursor ion
during the ionisation process. An ion with the appropriate dissociation rate versus
internal energy content may survive long enough to be extracted from the ion source
before it fragments, but may then fragment before detection;
ii. collision-induced dissociation (CID), in which the addition of internal energy to the
precursor ion occurs in a reaction region or collision cell. A gas is admitted to the
reaction region to induce dissociation following activation of the precursor ion by
collision with the neutral target gas.
The second mass analysis stage displays the spectrum of product ions resulting from the
fragmentation of the precursor ion.(3)

1.2. Mass Spectrometry of DNA
The use of mass spectrometry for the investigation of nucleosides and nucleotides is well
established.(43) El and Cl have only been used for very small species that are either
volatile or have been derivatised.(44) FD has also been used to provide molecular
weight and structural information for nucleosides and nucleotides.(45)(46)
Oligomers have been studied by PD and FAB. Longer strands of DNA could only be
analysed after they had been enzymatically digested into smaller fragments. PD has
been successfully used to observe protected oligonucleotides up to 12 bases in
length(47), whereas FAB has been used to analyse an unprotected oligonucleotide of 13
bases.(48) These were the largest oligonucleotides studied prior to the development and
application of the ESI and MALDI techniques.
ESI and MALDI are relatively new techniques that have revolutionised mass
spectrometry of DNA constituents by allowing much larger oligonucleotides to be
analysed. The only major problem with these techniques is their inability to deal with
high concentrations of salt. Oligonucleotides are sensitive to the presence of salt due to
their polyanionic phosphodiester backbone.(49) In addition to affecting the quality of
the ESI mass spectrum, the presence of salt can also influence ligand-DNA binding.(50)
This is because salt dependent electrostatic effects play a central role in the inter
molecular interactions involving nucleic acids. It has been found that univalent ions
11

substantially destabilise charged ligand-DNA complexes

at physiological

salt

concentrations due to a large unfavourable change in electrostatic ion-molecule
interactions.(50)
HPLC and CE have both been successfully coupled with ESI-MS. Bleicher and Bayer
were the first to report the analysis of oligonucleotides using HPLC coupled with
ESI-MS(51), which has subsequently been used to characterise DNA adducts.(52)
CE-ESI-MS preceded by enzymatic digestion of DNA has been used to analyse large
DNA strands and their adducts.(53)

1.2.1. Matrix-Assisted

Laser Desorption / Ionisation

of

Oligonucleotides
As with ESI-MS, early studies using MALDI concentrated mainly on peptides and
proteins.(9)(54-57)

MALDI has now been used to successfully characterise and

sequence both natural and modified oligonucleotides.
Initially, most MALDI analyses of oligonucleotides used matrices that had been found to
be suitable for the analysis of proteins. While using these matrices, only very small
oligonucleotides were detected successfully. Since then a range of MALDI matrices
specifically for oligonucleotides have been examined.(58)(59) 3-Hydroxypicolinic acid
was proven to produce the best mass spectra for poly A, poly G, poly C and mixed base
oligonucleotides.(5 8) The matrix used, as well as the concentration of the analyte in the
matrix solution and the substrate, have also been shown to influence the formation of
either singly or multiply charged ions.(60)
Addition of salts has also been shown to have an effect on the sensitivity, reproducibility
and accessible mass range in the MALDI analysis of oligonucleotides. Of the salts
tested, only ammonium acetate has been shown to improve MALDI spectra.(61) Other
studies have determined the tolerance levels for some of the more common impurities
such as sodium chloride.(62)
Molecular weight information for a variety of both modified and unmodified
oligonucleotides has been obtained by MALDI with an accuracy of up to ±0.06%.
C hem ically-m odified oligonucleotides have been shown to behave similarly to their
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unmodified counterparts. The mass of the modification moiety can be deduced through
comparison of the molecular weight of the oligonucleotide before and after
modification.(63-65)
A major problem with the MALDI analysis of oligonucleotides is the base loss induced
by the relatively high energy imparted during ionisation. Loss of bases occurs through
protonation of A, G and C bases, which then destabilises the N-glycosidic bond during
the desorption process.(66) This base loss appears to be the major cause of the decrease
in mass spectrometer response for mixed base oligonucleotides containing >20-30
nucleotides.(67) Modification of the bases, such as conversion of guanine to the 7-deaza
form, offers higher stability and increased sensitivity during MALDI analysis.(68)(69)
DNA segments as large as 500 nucleotides have been successfully detected by MALDI,
however, the resolution is still too low for sequencing strategies to be employed for
oligonucleotides of this length.(70)(71) Double stranded DNA has also been observed
using MALDI-TOF.(72)(73)
Some studies of oligonucleotide adducts have also been performed by MALDI. These
include

protein-nucleic

acid

complexes(74),

adducts

of polycyclic

aromatic

hydrocarbons (PAH’s)(75) and of the antitumour agent cisplatin.(76)
Studies of the fragmentation of oligonucleotides(77)(78) observed in MALDI spectra
have shown that the major fragmentation pathway is similar to that observed in ESI-MS.
This fragmentation is the loss of a base followed by the backbone cleavage of the 3' C-0
bond of the corresponding deoxyribose. Sequencing strategies using MALDI have been
demonstrated with both modified and unmodified oligonucleotides as models for
DNA.(79-84)
Initially, the mass resolution of MALDI was insufficient to enable the sequencing of
very large oligonucleotides. Recent studies by MALDI have concentrated on attempting
to increase its resolution.(85-87) The biggest advance to date has been the development
of delayed extraction (DE) MALDI TOF-MS which provided greater sensitivity and
resolution.

This has allowed oligonucleotides up to 50 bases to be routinely

sequenced.(88-90)
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1. 2. 2. Electrospray Ionisation Mass Spectrometry of DNA
Constituents
ESI-MS of an oligonucleotide was first reported by Covey and coworkers(91) in 1988
for a 14 mer with a molecular weight of 4262.8 Da. In this study, in the negative ion
mode, charge states ranging from the [M-6H]6' to [M-l 1H]11' were observed.
Oligonucleotides up to 80 bases can now be routinely studied by ESI-MS,(92) although
considerably higher mass species (up to a 133 mer) have been analysed with careful
attention to sample preparation. ESI-MS has been used to confirm the sequences of
synthetic oligonucleotides(93), detect modifications(94)(95), and to identify products of
unstable oligomer degradation in the analysis of oligonucleotides and antisense
oligonucleotides(96). Duplex DNA, DNA complexes (covalent and non covalent) and
megadalton DNA have also been studied by ESI-MS.
ESI-MS is used to verify synthetic oligonucleotide sequences because it is a rapid and
accurate technique requiring only very small (10-50 pmol) amounts of sample for
analysis.(93) Potier et <2/.(92) reported the accuracy of molecular weight determination
of oligonucleotides by ESI-MS to be 0.01% for oligonucleotides up to 80 mers, and that
a 132 mer could also be measured successfully, albeit with lower accuracy. Little and
coworkers (97) also used ESI-MS in conjunction with FT-MS for sequence verification
by molecular weight for oligonucleotides up to a 100 mer with an accuracy of 0.003%.
ESI-MS has also been used for the analysis of modified oligonucleotides from simple
monomers to oligomers containing up to 50 bases.(93)

Modifications such as the

incorporation of stable isotopes(94), modified bases(98), and phosphorothioate
linkages(94) have all been successfully verified by ESFMS.
Antisense oligonucleotides have also been studied by ESI-MS.(96)(99) Interest has
increased recently in this area because they are being used as potential therapeutic agents
as antiviral drugs (in particular against HIV.) They are complementary to specific RNA
sequences and bind to messenger RNA (m-RNA), thereby inhibiting the synthesis of
specific proteins or the expression of the targeted gene.(96)(99)

Deroussent and

coworkers used ESI-MS to determine the masses of antisense oligonucleotides and to
characterise the purity of the oligonucleotide being tested for pharmacological
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studies.(96) The method was optimised with phosphodiester oligonucleotides and then
applied to antisense oligonucleotides.

1.2.2. a. ESI-MS of Megadalton DNA
Megadalton DNA has been successfully ionised and the molecular weight determined by
ESI-MS.(100)(101) Early studies(102) were unable to confirm the actual molecular
weight because the individual charge states were unresolved, so it was assumed that the
m/z value of the band maximum corresponded to the most probable charge state of the
most abundant oligomer.
Fuerstenau and Benner have also used TOF-MS to detect the electrosprayed ions from
large DNA.(IOO)

The charge of the ion was determined in a Faraday cage charge

detector. The entrance and exit signals from the passage of each ion provide the ion
velocity which allowed for the calculation of the m/z for each ion and the mass could
then be determined.
Cheng and coworkers reported on FT trapping of individual highly charged plasmid
DNA(lOl). Charge state shifting was accomplished by creating multiple peaks from the
same ion, so that molecular weights could be calculated. Before this FT-MS method for
measuring megadalton size molecules, this group measured large coliphage T4 DNA
ions up to 108 kDa based on the measurement of the induced current and therefore the
charge. This approach, however, showed much less precision.(100)(101)(103)

1.2.2. b. Charge-State Reduction
Charge-state reduction is the shift of charge states normally observed by ESI-MS to a
higher m/z ratio to simplify analysis of complex mixtures. This is normally achieved
through the addition of acids, or the addition of organic bases such as diamine.(104-106)
When d(pT)i2 was analysed in negative ESI-MS, the charge state distribution showed a
maximum at [M-9H]9', but after charge state reduction the [M-5H]5’ ion was the
maximum charge state observed. This was thought to occur due to the shielding of
charge sites on the oligonucleotide by ammonium ions. Addition of increasing amounts
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of either acetic or formic acid shifted the charge state distribution progressively lower to
the charge states [M-4H]4' and finally [M-3H]3\(105)
Charge state reduction can also be used to more efficiently analyse oligonucleotide
mixtures. A mixture containing equal concentrations of d(pT)i2, d(pC)i2, and d(pG)io
was analysed by ESI-MS. Each component gave several charge states, and many of the
charge states overlapped. Following charge state reduction, the spectrum consisted of
one charge state for each component, thereby reducing the mass spectral complexity of
the mixture.

All components were then observed to be well separated and easily

identifiable.(105)

I.2.2.C. Oligonucleotide Desalting Techniques for ESI-MS Analysis
The quality of the electrospray spectra is greatly affected by the presence of involatile
salts. The spectra may show low signal intensity and clustering with salt ions, making
molecular weight determination difficult. In severe cases it can even preclude spectral
interpretation.

Oligonucleotides are intrinsically more sensitive than proteins to the

presence of salt(107) owing to their polyanionic phosphodiester backbone(49).
Common salt species observed include Na+ and K+.(108)(109)
Common desalting techniques often rely upon centrifugation or off-line micro-dialysis.
Centrifugation has been used in conjunction with size exclusion chromatography media
using both Bio P-2 gel (1800 Da cutoff) and Sephadex G-10 gel (700 Da cutoff) to desalt
carbohydrates for FAB analysis. This technique should also be applicable for ESI-MS of
oligonucleotides.(l 10)(111) The P-2 gel was found to be sufficient to permit FAB mass
analysis without any additional treatment of the sample. The G-10 gel displayed a much
lower desalting capacity and molecular ion species were only obtained for sequences up
to a 5 mer, however when the G-10 gel was used with permethylation the sensitivity and
the number of structurally informative peaks increased.(l 11) Centrifugal size-exclusion
chromatography is highly effective, extremely easy and very rapid method for desalting
carbohydrate samples. The number of samples that can be desalted simultaneously is
limited only by the size of the centrifuge used.(l 11)
Wu et al.{ 109) developed an online desalting system for ESI-MS. In this approach they
infused the solution to be sprayed inside the dialysis tube that was contained inside the
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probe tip, which caused the exchange of small molecules or ions (such as Na+) with
more volatile components (such as N H /). The buffer flow rate is important for this
technique because if it is too low or too high, incomplete desalting occurs. Results
obtained at neutral pH also suggest that native protein conformations and noncovalent
complexes should be preserved through this rapid desalting ESI process.(109)
Ammonium precipitation has also been another common desalting method used on
oligonucleotides. This method uses precipitation of the oligonucleotide in ammonium
acetate to replace Na+ ions with N H / ions. In a report by Stults and Marsters this
desalting technique was applied to a 30 mer.(l 12) The resulting spectra displayed much
sharper peaks, with the largest peak containing no sodium ions. Some Na+ adducts were
still observed but these had much lower abundance. This technique is not quantitative,
however, as the effectiveness is a function of the sequence length, and loss of analyte
during precipitation occurs.(49)
Addition of organic solvents has also been used to suppress adduct ion formation and to
increase the ESI response for the molecule of interest.

Changes in the solvent

composition using various percentages of acetonitrile did not substantially alter the ESI
mass spectra.

Completely aqueous solutions gave similar spectra, although the

electrospray was more difficult to stabilise.(l 12)

When strong bases, such as

triethylamine (TEA) or piperidine were added, the best cation adduction suppression was
obtained. The level of cation adduction could be reduced up to 100-fold. With the
co-addition of imidazole, an additional increase in the sensitivity was also observed.(49)
Besides the pH and the nature of the solvent, base composition of the oligonucleotide
has an impact on the signal intensity. When Bleicher and Bayer studied the sequences
d(A)io, d(G)io, d(C)io and Tio, all of the oligomers behaved similarly except Ti0.(108)
This sequence displayed a greater signal intensity than the others, which they suggested
was because it is the only monomer that contains an acidic N-H bond.

1. 2. 2. d. Noncovalent Complexes By ESI-MS
ESI-MS is a very gentle ionisation technique and can therefore be used to study the
noncovalent interactions that occur in solution, as it allows experiments to be performed
under near physiological conditions.(113) ESI-MS has advantages over other techniques
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used to study noncovalent interactions, because it is more sensitive and more specific
than UV or fluorescence assays.
To date noncovalent biomolecular complexes studied include:
enzyme-substrate, (114)
protein-ligand, (115-122)
multimeric proteins, (123-125)
DNA duplexes,(126-129) and
DNA-ligand complexes (130-136)
There has been much discussion over whether the observation of noncovalent complexes
between biomolecules by ESI-MS necessarily reflect specific solution interactions.(137)
Evidence both for and against such observations has been published.

In studies

supporting the existence of noncovalent complexes in ESI-MS, Ganem(120) used
MS/MS to prove that the interactions between a receptor (FKBP) and two ligands
(rapamycin and FK506) were in fact specific noncovalent interactions. The receptor
binds to both ligands, but when the receptor was denatured by lowering the pH all
complex ions disappeared from the spectra, indicating that the binding was specific.
MS/MS was then used to support the notion that the binding was noncovalent, by
demonstrating that the energy required to dissociate the FK506 ligand from the receptor
was one tenth of that required to break a covalent amide bond within the receptor.
Ogorzalek-Loo and coworkers(l 13) showed that when ribonuclease-S is enzymatically
cleaved to yield S-peptide and S-protein, there are selected conditions where they can
reform ribonuclease-S. No homodimers were observed, only heterodimers, indicating
specific binding rather than random aggregation in solution or during the ESI process.
When the pH of the solution was lowered, no complex peaks were observed, as was
expected if the binding were specific.
Suizdak and coworkers(138) have demonstrated, for the first time, that very large
noncovalent complexes can survive the ESI-MS process in their native conformation.
They passed a live virus, tobacco mosaic virus, through a mass spectrometer and
collected the electrosprayed virus on a plate before the detector. Transmission electron
microscopy revealed that the tobacco mosaic virus retained its rod-like structure.
Confirmation that the virus was still intact was provided when the virus was observed to
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be still capable of infecting the tobacco plant, which shows that the noncovalent
biomolecular complex was unaltered through the ESI-MS process.
Cunniff and Vouros(139) discovered in studies using cyclodextrin, that not only do
aromatic amino acids and peptides containing aromatic moieties form complexes as
expected, but that any amino acid or oligopeptide will produce peaks in ESI mass
spectra, which correspond to a complex with cyclodextrin.

The results from these

studies also suggested that cyclodextrin-amino acid complexes detected by ESI-MS may
not be inclusion complexes but rather electrostatic adducts.
In studies by Ding and Anderegg(140) specific and nonspecific noncovalent dimer ions
of oligonucleotides were observed.

The appearance of these nonspecific dimers

appeared to be concentration dependent. When the concentration of the two strands was
reduced by a factor of ten, ions from all the dimers disappeared.
In recent studies by Chillier and coworkers(141) it has been shown that under certain
conditions ESI-MS does not reflect equilibrium ion abundances in the electrosprayed
solution. One such case is that of the free-base octaethylporphyrin, which in solution is
predominantly the doubly-charged species, yet when it is electrosprayed only the singly
charged species is observed. The conversion from dication to monocation appears to
occur fairly late in the ESI process, after the dications are sampled into the atmosphere /
vacuum interface and before mass analysis.
Results presented by Aplin et a/.(137) indicated that complexes observed between
peptides and porcine pancreatic elastase (PPE) do not always fully reflect structurally
specific interactions.

They concluded that at this point in their research it was

impossible to give a general answer to whether ions observed in the gas phase are
indicative of what is occurring in solution.
Smith and Light-Wahl conducted studies(142) to determine if it was possible for
ion-neutral or ion-ion processes to produce gas-phase concentrations of noncovalent
complexes. Models for the ESI-MS process imply that after the production of individual
molecular species, the concentration of neutral molecules should be zero or very small in
the gas-phase. Ion-molecule reactions are thought to have no effect since they only
become important at gas-phase neutral concentrations far greater than can be produced
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for solutes from electrosprayed solutions. Ion-ion processes are unlikely to result in the
formation of the same species, owing to repulsive long range coulombic forces. Hence it
was suggested that noncovalent complexes must be maintained or formed prior to
completion of the evaporative loss of solvent by the ESI process. For example, with
higher order protein structures coulombic considerations dictate that the loss of such
structure will almost always be irreversible in the gas-phase.
Smith et al.{ 142) concluded that while nonspecific associations are not likely to form in
the gas-phase, each case has to be independently proven.

Proof of noncovalent

interactions is normally provided by negative data, i.e., the complex disappears on
denaturation of the host, replacement of the host, alteration of pH, or on desalting of the
sample.

Some of these tests support their theory but are inconclusive because the

changing of the parameters may also change the conditions required to form the
aggregate. A better control would be to substitute the “guest”. MS/MS is also an
effective method to indicate if the interaction is noncovalent. A good indication of
aggregates, especially for DNA duplexes, is if peaks corresponding to the homodimer
are observed as well as the heterodimer.
These studies show that noncovalent interactions can be monitored by ESI-MS, but that
it is impossible to give a general answer to whether it is indicative of what is happening
in solution. Each individual case has to be studied separately and proven accordingly.

1. 2. 2. e. Duplexes
Duplexes are helical double-stranded DNA formed by Watson-Crick base-pairing, i.e.,
A-T and G-C. The observation of duplex DNA by ESI-MS was first reported in early
1993 by Light-Wahl et al{ 129) when they acquired an ESI mass spectrum after
annealing two complementary 20-mer strands of DNA. This was closely followed in the
same year by a report by Ganem et al{ 128), who studied the duplex formation of self
complementary DNA strands as well as a pair of complementary sequences. Doktycz et
al.{\21) showed that duplexes could also be observed when ESI-MS was performed with
an ion-trap mass analyser. MS/MS was performed on the 10-mer duplex [M-5H]5
charge state. It was found to dissociate only into each of the individual strands, as was
previously demonstrated with a quadrupole mass analyser.(128) Studies by Bayer et
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al.( 126) concentrated on hybridisation of mixed double strands of natural and chemically
modified oligonucleotides by ESI-MS. This is thought to be very important because it is
this hybridisation from an antisense oligonucleotide which is expected to act in the target
cells to prevent translation and inhibit gene expression. The signal intensity of the
duplex increased with the length of the complementary strand.
In addition to duplexes, ions corresponding to a noncovalent, four stranded
oligonucleotide d(CGCG4GCG)4 have been observed by ESI-MS.(143)

These

structures were stabilised by the cations and when the solution was desalted no
quadruplex was observed by ESI-MS.

1.3. Tandem Mass Spectrometry (MS/MS) of
DNA Constituents
1.3.1. Fast-atom Bombardment (FAB) MS/MS
Fast-atom bombardment (FAB) MS/MS has been used extensively to obtain structural
information on nucleosides, nucleotides, small oligonucleotides and some of their
adducts. Analysis of nucleosides by FAB-MS/MS was first reported in 1983. These
molecules were found on fragmentation to form the sugar and BH2+ ions and to a lesser
extent specific bases and fragmentation across the sugar group.(144-147)
The earliest report on FAB-MS/MS studies of nucleotides was in 1984. Nucleotides
fragmented to form mainly BH2+ in the positive ion mode and B', PO3' and H2PO4' in the
negative ion mode. Other fragmentation products observed to a lesser extent, in both the
positive and negative ion modes, were fragmentation across the sugar group, and the loss
of H20 and CH20 from the protonated or deprotonated molecular ions.(144-146)
The first study of oligonucleotides by FAB-MS/MS was made in 1983 when the
oligomers GGTA and TACC were shown to yield sequence information in the negative
ion mode.(144) Phillips and McCloskey(148), and Gross and coworkers(145), utilised
FAB-MS/MS for the extensive characterisation of dinucleotides as they are the smallest
subunit of nucleic acids that contain sequence information. Ions representing the bases
were generally amongst the most abundant fragments in both positive and negative ion
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modes. The [M-H]' ion fragments were observed to produce ions from the 5' terminus
more readily than from the 3' terminus. Therefore, the abundance of the 5' base of the
dinucleotide is greater than that for the 3' base.

The reverse is observed for

fragmentation of [M+H]+ as the 3' base is of greater abundance. The only exception to
this observation is when thymidine (T) is the 3' base, as no peak for it is observed in the
positive ion MS/MS spectrum. In ribodinucleotides the same observation was made for
Uracil (U). The absence of protonated T was attributed to the greater stability of the
thymidine glycosidic bonds. Isomeric dinucleotides can be distinguished on the basis of
this fragmentation. The preferred loss of the 5' base to the 3' base in negative ions
becomes less significant for higher oligonucleotides so it cannot be used unequivocally
for the assignment of the 5' base.
Studies of nucleoside and nucleotide adducts with genotoxic compounds have also been
analysed by FAB-MS/MS.

Tomer et al.(149) studied 12 modified nucleoside and

nucleotide adducts bonded to various pyrrolizine alkaloid metabolites by FAB-MS/MS.
Sites of base, sugar and alkaloid modification were identified, and in some cases
information as to the location of the alkaloid-base bonding was observed. The most
informative product ion spectra were those obtained from the MS/MS of the [M+H]+
ion, whereas fragmentation of [M+K]+ and [M-H] provided mainly confirmatory
information.

1.3.2. Electrospray

(ESI)

Tandem

Mass

Spectrometry

(MS/MS)
There have been relatively few reports concerning ESI-MS/MS of oligonucleotides,
which may in part be because of the difficulty associated with assigning the charge states
to the product ions produced from multiply-charged precursor ions.(150)
Scheme 1.1 shows the nomenclature for the fragmentation of oligonucleotides based on
the system used for peptides and proteins(34), which was proposed by McLuckey et
al.( 151) and has now been widely adopted. This scheme is illustrated with a triply
charged tetra-nucleotide, bases B1~^B4. They developed this new nomenclature scheme
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because the original scheme proposed by Cemy et al.( 152) could not fully account for all
of the product ions formed in the MS/MS spectra of oligonucleotides.
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Scheme 1.1: Nomenclature for ESI-MS/MS fragmentation of oligonucleotides
McLuckey and coworkers(151)(153)(154) studied both modified and unmodified small
oligonucleotides (up to 12 mer), by ESI-MS/MS with a quadrupole ion trap. All ions
studied showed structurally informative fragmentation.

They applied a third mass

spectrometry analysis step to provide complete sequence information. Complementary
fragment ions were normally observed in these spectra. Complementary ions result from
the single cleavage reactions of the precursor ion, with the charge being shared among
the two product ions. Both these ions are normally observed in the spectrum. If the
parent ion charge state is known, and one of a set of complementary peaks is also
known, the pair can be identified in the spectra by charge separation ratios.
McLuckey and coworkers established a number of rules for the MS/MS of multiply
charged oligonucleotide anions. They were:
• for highly charged anions, charged bases are lost in preference to neutral bases;
• charged bases are lost in the order of preference A' > T > G", C' independent of chain
position (first decomposition step);
• in the absence of a preference for base loss, the 3' residue is the least likely to be lost;
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• the second decomposition step is the cleavage of the 3' C-0 bond of the sugar from
which the base is lost;
• loss of the PO3' group from phosphorylated ions can compete with base loss;
• complementary ions are normally observed, provided both are stored in the ion trap;
• the maximum charge state for anions is equal to the number of bases - 1 or the
number of phosphodiester linkages;
• the lower the total charge state, the lower the number of mass analysis stages that can
be performed;
• these rules also apply for modified oligonucleotides.
Gentil and Banoub performed a study of MS/MS of oligonucleotides on a triple
quadrupole mass spectrometer, comparing these results with the results obtained by
McLuckey.(151)(153)(154) To try and obtain similar conditions to those in the ion trap
they changed the collision gas from argon to helium.(150) This appeared to have little
impact because the ESI-MS/MS spectra obtained using both collision gases were
identical. They were unable to obtain similar results and concluded that the difference in
the fundamental behaviour between the two mass analysers could be due to much higher
energy being imparted to these oligonucleotide molecules in the triple quadrupole
experiments.
ESI-MS/MS has also been used to differentiate between isomeric DNA.(150) Two
series were analysed by ESI-MS and displayed an identical series of multiply charged
molecular ions. MS/MS studies produced a complete or very near complete set of singly
or doubly-charged w series ions. Each hexamer in the first series was unable to be
completely sequenced, however those in the second series had their sequences fully
confirmed.
MS/MS studies have been performed on antisense oligonucleotides.(99) The exact
sequence of these molecules is very important, since altering a sequence by as little as
one base is enough to potentially change the action of these therapeutic agents. Baker et
al.(99) used MS/MS to verify the sequence of some synthetically prepared
methylphosphonate oligodeoxyribonucleotides.

MS/MS of the doubly and triply

charged molecular ions of this sequence provided little structural information as little
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fragmentation was evident. Peaks owing to part of the Y series were identified, but most
fragmentation peaks were independent of the sequence. The best result was obtained
from MS/MS of the [M+4H]4+ molecular ion for which considerable information was
obtained, confirming the expected sequence.
Sequence information for an 8mer to a 25mer were obtained by Little et al using an
ESI-FTMS system.(155) Fragmentation was obtained by MS/MS in the ICR cell and by
nozzle skimmer dissociation, with similar fragmentations being obtained in each case.
For the sequences 8-14 bases in length, full sequence information was obtained. In most
cases the total sequence was determined from the w series alone. The (an-Bn)x" series
was also instrumental in the sequence determination. For the larger sequences, 21mer
and 25mer, only partial sequence information was obtained.
McLuckey and coworkers(156) have studied the competition between the loss of the
nucleobase as a neutral and the loss of the base as an anion. They used a series of
oligonucleotides, monomers through to hexamers, that only contained adenine for this
study. ESI-MS/MS of the [M-H]' to [M-5H]5' molecular ions were compared. The
likelihood of the loss of a charged versus neutral adenine was found to be strongly
dependent on the charge state of the precursor ion, as might be expected. Increasing the
charge state was found to favour charged base loss.

1.4. DNA-Ligand Complexes
DNA can act as a receptor for a number of different types of ligands. These include
proteins, peptides, metals, metal complexes, and alkylating agents. Ligands can bind to
either the major or minor groove of DNA by intercalation, groove binding, alkylation,
crosslinking, electrostatic forces, or some combination of these. The binding can be
either reversible (noncovalent) or irreversible (covalent). Figure 1.4 displays some of
the more common forms of DNA-ligand binding.
Intercalation occurs when a planar or approximately planar aromatic ring system is
inserted between DNA base-pairs. Groove binding is when the ligand twists so it can lie
within either the major or minor groove. External electrostatic interactions are when the
ligand binds along the exterior of the helix through interactions which are generally non25

specific and primarily electrostatic in origin. Crosslinking occurs when the ligand binds
in at least two places, normally on two separate DNA strands, linking them together.(l)

groove binding

intercalation

Figure 1.4: Some of the types of DNA-ligand binding.(l)
DNA-ligand interactions have been studied extensively to aid in the design of more
effective antitumour agents.(157) Structural studies of DNA-ligand interactions have
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been performed mainly by NMR spectroscopy(158) and x-ray crystallography(159), and
to a lesser extent by circular dichroism (CD)(160) and fluorescence spectroscopy.(161)
The sequence selectivity of antitumour agents is normally determined by methods based
on molecular biology.(162)

Mass spectrometry is increasingly being used for the

characterisation and identification of DNA-ligand interactions since it offers advantages
in terms of speed and sensitivity of analyses compared to other structural techniques.
One of the most extensively studied antitumour agents is cisplatin. It is primarily used
to treat testicular cancer, and to a lesser extent other cancers such as ovarian cancer.
Cisplatin is a bidentate ligand and as such can bind to two adjacent guanines on the same
DNA strand (intrastrand binding), two guanines separated by another nucleotide on the
same chain, or two guanines on different DNA strands (interstrand binding).(163)
Early studies of cisplatin complexes with nucleoside analogs were observed using
EI-MS.(164)(165) The limitations of this technique (volatility and mass range) resulted
in only neutral complexes with single bases being analysed.

Pyrolysis mass

spectrometry with El was later used(166) to analyse a series of cisplatin-DNA
complexes in the 100 to 300 Da range from the fragmentation of the cisplatin-salmon
sperm DNA complex. FAB-MS, and more recently MALDI and ESI-MS, have been
used for the study of DNA-drug binding. Martin et al. (163) published the first FAB
mass spectrum of a platinated oligonucleotide which showed cisplatin bound to a
tetramer. This study showed that the platinum (Pt) was bound to bases in adjacent
nucleotides, with one base usually being guanine. FAB-MS/MS, in the positive ion
mode, produced fragment ions consisting of Pt-base, Pt-nucleoside, or Pt-nucleotide
complexes, whereas the fragments produced in the negative ion mode were mainly
nonplatinated sequence ions. Further studies by Costello et al.( 164) confirmed this.
Prior to the development of ESI-MS and MALDI, studies involving larger
oligonucleotides were limited as FAB was only capable of measuring small (up to
13 mer) oligonucleotides. ESI-MS and MALDI made it possible to obtain spectra of
higher molecular weight DNA-ligand complexes. In 1991 Poon et al.(\61) published
the first report on the application of ESI-MS to cisplatin.

They gained structural

information from the ESI-MS/MS of cisplatin, but never applied it to cisplatin-DNA
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complexes. The first report of the cisplatin-DNA complex detected by ESI-MS was that
by Wickham et £*/.(107) in 1995.
The use of MALDI to study cisplatin was reported by Costello et al.{16)

It was

concluded that MALDI provided fairly accurate molecular weight information for
cisplatin adducts of oligonucleotides as well as their unplatinated analogs. The best
sensitivity was obtained in the negative ion mode, using IR irradiation and sinapinic
acid.
Gale et al.{ 131) were the first to report the use of ESI-MS for detection of a noncovalent
duplex DNA-minor groove binder complex. They studied the interaction between the
self complementary DNA strand 5'-d(CGCAAATTTGCG)-3' and the antibiotic
distamycin A. Distamycin binds noncovalently in the minor groove of the AATT or
ATTT duplex region.

Hydrogen bonding, van der Waals forces, and electrostatic

interactions account for the sequence selectivity of this molecule. They later expanded
this study to include the minor groove binding molecules pentamidine and Hoechst
33258.(132)(133) Product ion spectra of the duplex-ligand noncovalent complexes were
obtained. The dissociation behaviour of all three complexes was similar. This may have
been due to the absence of significant binding differences between the three drugs. It
may also have been caused by the dissociation mainly being influenced by the duplex,
which was constant for these experiments.
Other ESI-MS investigations of noncovalent complexes include those performed by Gao
et al.( 136) and Hsieh et a/.(130) Gao and coworkers(136) studied the neocarzinostatin
drug-bulged DNA complex.

Hsieh and coworkers(130) studied actinomycin D and

single stranded DNA complexes. Both groups utilised ESI-MS and ESI-MS/MS to
observe the complex and prove the specificity of the interaction.
Wickham et a/.(168) published the first report of a covalent ligand-duplex DNA adduct
by ESI-MS. They studied the antitumour antibiotic hedamycin and its binding to the self
complementary oligonucleotide 5'-d(CACGTG)-3'. The specificity of the base-paired
duplex was proven by a titration experiment involving alkylated and nonalkylated
complementary strands. No peaks due to duplex formation for the sterically hindered
alkylated DNA were observed, as was expected. On further addition of free DNA, a
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duplex was formed. Further studies by this group(107) also examined the covalent
adduct formed between cisplatin and DNA.
Other covalent complexes studied by ESI-MS include work by Sigurdsson et al.( 169)
and Chaudhary et al.{52) Sigurdsson et al.( 169) used ESI-MS to determine the mass of
the complex formed by an agent, 2,3-bis-(hydroxymethyl)-pyrrole linked to distamycin
and crosslinked to DNA. This agent contains both covalent and noncovalent binding
regions that contribute to the specificity of the interaction. MALDI has also been used
to study covalently crosslinked agent-DNA complexes.(170) ESI-MS has also been
linked with liquid chromatography (LC) to characterise nucleoside adducts. Chaudhary
et al.(52) used LC-ESI-MS and LC-ESI-MS/MS to study the endogenous adduct of
malondialdehyde with 2'-deoxyguanosine.
For antitumour drug design it is important for the exact nature of the interaction between
the ligand (drug) and DNA to be determined. This requires the identification of DNA
binding characteristics, which leads to the design of effective analogues. ESI-MS and
ESI-MS/MS have, and will continue, to expand studies in this area.

1. 5. Pyrindamycins
Pyrindamycins A and B are two potent antitumour antibiotics that derive their biological
properties through sequence selective DNA minor groove alkylation.

The

pyrindamycins are known also as duocarmycin C2 and Cl respectively*. The different
names arose because two different Japanese research teams discovered these compounds
simultaneously. Ichimura et al. published their findings on duocarmycin C l(171) and
duocarmycin C2(172) in September 1988. This was closely followed in a report by
Ohba et

of the structure of both pyrindamycins in October 1988. Both groups

isolated the antibiotics from the culture broth of a streptomycete which had been isolated
from soil samples.

* NOTE: this group, known as the duocarmycins, also contains A, SA, B1 and B2.

29

The structures of pyrindamycin A and B, displayed in Figure 1.5, were verified by a
combination of mass spectrometry (EI-MS), high resolution EI-MS, NMR, UV/VIS, IR
and X-ray crystallographic analyses.(171)(173)(174)

b)

Figure 1.5: The structures of a) Pyrindamycin A, and b) Pyrindamycin B
Pyrindamycin A and B were found to be active against Gram-positive and
Gram-negative

bacteria,

and exhibit

strong therapeutic

effects

against both

drug-sensitive and drug-resistant P388 leukemia cells in mice. They were not, however,
effective towards solid tumours.(171)(173-175) These antibiotics also strongly inhibit
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DNA synthesis, but have little effect on RNA or protein synthesis.(175) Pyrindamycin
A and B possess a pharmacophore similar to that of CC-1065 shown in
Figure 1.6.(176)(177)

Figure 1.6: Structure of CC-1065 and the Common Pharmacophore
CC-1065 is an extensively characterised antitumour antibiotic and is one of the most
cytotoxic antitumour agents known.(176-178)

The development of CC-1065 as an

antitumour agent was stopped, however, because of the delayed death of mice at
subtherapeutic doses. The delayed toxicity of CC-1065 is thought to be due to the extent
of noncovalent binding stabilisation which renders the DNA alkylation irreversible. In
contrast, the alkylation by the pyrindamycins is reversible and the pyrindamycins do not
exhibit the same highly toxic effects.(178-181)
The pyrindamycins act at the cellular DNA level.(178) When the alkylation properties
of pyrindamycin A and B and the agent known as duocarmycin A were studied, it was
revealed that the sites of alkylation for each of the antitumour agents were
indistinguishable.

This suggested that a common agent, duocarmycin A (shown in

Figure 1.7) was the reacting species.
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Figure 1.7: Structure of Duocarmycin A
It was supposed that the halogens of pyrindamycin A and B were cleaved in the culture
medium or cells, resulting in their conversion to duocarmycin A.(177)(178)(182)
Hence, pyrindamycin A and B are considered to be prodrugs of duocarmycin A.(178)
Although the sites of alkylation were indistinguishable, the efficiency of the alkylation
(judged by the concentration of the agent required for its observation) proved dependent
on the structure of the agent and the incubation conditions.(182)(183) For example, the
reaction of duocarmycin A at 4°C for 24 hrs, led to more extensive alkylation than with
the pyrindamycins (A>B). This compares to the reaction at 37°C for 24 hrs, where the
pyrindamycins

showed more extensive alkylation than duocarmycin A, (and

pyrindamycin B>A). The dependence on the reaction conditions could be accounted for
by the relative availability of the agents (i.e. the stability of pyrindamycin A and B >
duocarmycin A) under the reaction conditions and their relative rates of DNA alkylation
(duocarmycin A > pyrindamycin A > pyrindamycin B).(177)(182)(184) The depth of
minor groove penetration by the agent and the steric accessibility of the alkylation site
also contribute to the observed efficiency or extent of DNA alkylation.(179)(185)

1. 5. 1. Sequence Selectivity of Alkylation
Details of the preferred DNA alkylation sites and hence the sequence selectivity of the
pyrindamycins have been obtained from the thermally-induced strand cleavage at the
sites of covalent modification of double-stranded DNA, after exposure to the agents.
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Gel electrophoresis of the resulting DNA, under denaturing conditions, along with
Sanger dideoxynucleotide sequence reactions followed by autoradiography, permitted
identification of the alkylated sites.(177)(179) The preferred sites of DNA alkylation of
the pyrindamycins proved to be an adenine (A) flanked by two 5'- A or T bases. Thus, it
has been shown that the pyrindamycins have a strong preference for the sequence of the
three bases in the following order :
5'-(AAA)-3' > 5'-(TTA)-3' > 5'-(TAA)-3' > 5'-(ATA)-3'
The first two sequences are high affinity sites and the second two are low affinity sites.
In addition, the alkylation exhibited a strong, but not exclusive, sensitivity to the fourth
base, preferring an A or T versus G or C as the flanking 5'- base. The lower affinity
sequences, more than the high affinity sequences, preferred alkylation sites with a purine
(A or G) versus a pyrimidine (T or C) preceding the A alkylation site.( 177)(182)
One problem with this sequencing method is that only adducts susceptible to thermal
N-glycosidic bond cleavage (adenine N3 and guanine N3 and N7 alkylation) are
observed. Any additional alkylation reactions, if present, would not be detected.(179)
NMR and mass spectrometry, therefore, have potential advantages over this technique
for identifying alkylation sites because it should be possible to observe the presence of
any additional adducts, and the process would be much faster. Even with these
advantages, the use of these techniques (especially mass spectrometry) in this area has
not been very widespread. The work of Boger et al.{ 184) is one of only a handful of
papers that have used mass spectrometry, and even then it appears that it was only used
in the derivation of molecular weight information concerning the adducts.
The pyrindamycins, once converted within the cell to duocarmycin A, alkylate the N3
position of adenine in the DNA minor groove. This reaction is displayed in Scheme 1.2
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ADENINE
N3

ADENINE

\

Scheme 1.2: The Proposed Mechanism for the Reaction of Pyrindamycins with Adenine
Sites within DNA.
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Boger et al.( 185) proposed that adenine alkylation by the pyrindamycins proceeds via
the following model: “The binding of the agent spans 3.5 base-pairs in the 3’- to 5’direction from the adenine N3 alkylation site. The hydrophobic concave face of the
agent is deeply imbedded in the minor groove and the polar functionality of the agent
lies on the outer face of the complex. This explains the observed absolute requirement
for the first three base-pairs, and to a lesser extent the fourth base-pair, of the alkylation
site to be A or T.”(177-179)(182)(185)(186)
Guanine has been shown to be a second target of duocarmycin A in DNA. Results by
Sugiyama et al.{98) indicate that the N3 of guanine can nucleophilically attack the
cyclopropane subunit of duocarmycin A. This guanine alkylation appears to occur in
oligonucleotides that lack a high affinity alkylation site or when adenine alkylation sites
within AT-rich regions of labeled restriction fragments are not available.(98)(185)

1. 5. 1. a. The Role of Noncovalent Binding
During the development of the pyrindamycin DNA alkylation selectivity model, the
most commonly asked question was, “what role does noncovalent binding play?” There
have been many studies that have addressed this question.(179)(181)(187-190) In a
study by Boger et a l in 1991(187), it was discovered that in the absence of noncovalent
binding, the alkylation of DNA by the pyrindamycins was nonselective. Initially it was
thought that a DNA autocatalytic phosphate activation of the alkylation reaction (Lewis
acid complexation/protonation) and the stereoelectronic effects associated with the
cyclopropane alkylation contributed uniquely to the alkylation selectivity. Additional
studies by Boger and co-workers in 1993 and 1995 further supported the role of
noncovalent binding in alkylation selectivity. Boger et al observed in 1993(181) that
the adenine N3 addition reaction does not occur with free adenine. This reinforced the
view that it was the noncovalent binding stabilisation derived from hydrophobic binding
and van der Waals contacts that led to alkylation selectivity. This was further supported
in 1995(188) when studies by Boger et a l found that the incorporation and conversion
of a natural enantiomer of duocarmycin SA into an agent exhibiting the DNA selectivity
of a typical unnatural enantiomer, by reversal of the binding orientation of the agent, is
only consistent with a model where the AT-rich noncovalent binding selectivity and
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depth of minor groove penetration surrounding the alkylation site are controlling the
sites of alkylation.

1. 5. 2. Unnatural Enantiomers
The alkylation properties of some of the unnatural enantiomers of these agents have also
been studied.( 185)( 191-193)

The unnatural enantiomers when compared with their

natural forms were found to exhibit the same sequence selective alkylation. This results
from the diastereomeric nature of the adducts. The unnatural enantiomer binding differs,
however, as it starts at the 5'- base preceding the adenine alkylation site and extends
across the adenine and the adjacent two bases in the 3'- direction.

This reversed

orientation binding is required to permit the potential adenine alkylation site access to
the least substituted carbon of the activated cyclopropane. (185)(191)(192)

1. 6. Outline of this Work
The literature reviewed in this chapter has shown that there have been relatively few
studies of the ESI-MS and ESI-MS/MS of oligonucleotides, especially compared to
peptides and proteins. Characterisation of these molecules was difficult prior to the
introduction of the ESI and MALDI techniques, however earlier mass spectrometry
ionisation methods have been applied extensively to the characterisation of individual
bases, nucleosides, and nucleotides, with oligonucleotide studies limited to 13 mers.
The gentle ionisation conditions of ESI-MS have also shown it to be feasible for the
study of both covalent and noncovalent drug-oligonucleotide interactions. These studies
have also, however, been very limited.
The aim of the work presented in this thesis was to characterise small oligonucleotides
by ESI-MS and to then investigate the feasibility of this technique for studying
interactions of the oligonucleotide with alkylating agents that bind in the minor groove
of DNA. The example chosen for this was the antitumour agent pyrindamycin A (PyA).
The instrumental and experimental details for the ESI-MS and ESI-MS/MS studies are
described in Chapter 2.

Chapter 3 describes a study of small oligonucleotides

(2-12 mers) by ESI-MS/MS as a precursor to the study of oligonucleotide adducts, since
prior to the commencement of this study there had been only a limited number of
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ESI-MS/MS studies of oligonucleotides. Chapter 4 details the characterisation of the
adducts formed between pyrindamycin A and self complementary oligonucleotides by
ESI-MS and ESI-MS/MS.

Overall, this work demonstrates the potential of mass

spectrometry as an aid in drug design research.
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2. Experimental
2.1. Oligonucleotides
All di- and tri-nucleotides were purchased from Sigma (St. Louis, MO) and used without
further

purification.

5'-d(AGGCCT)-3',

The

and

the

5'-d(CGGT AATTACCG)-3 '

deoxyribonucleotides
sequences

and

used

for

5'-d(CACGTG)-3'
the

pyrindamycin

5'-d(CGCGAATTCGCG)-3',

were

and
studies,

synthesised

"trityl-on" with an Applied Biosystems Model 381A DNA synthesiser, using
P-cyanoethylphosphoramidite chemistry. The crude "trityl-on" oligonucleotides were
purified on a Waters Delta-Pak C l8 reversed-phase HPLC cartridge system with a linear
gradient of acetonitrile in 0.1 M aqueous ammonium acetate (pH 7.0) at a flow rate of 1
mL min 1 over a period of 30 mins for the trityl-on sequence, and 20 mins for the
detritylated sequence. The purified oligonucleotides were detritylated with 80% acetic
acid and re-chromatographed using the same stationary phase and solvent system.
Figure

2.1

displays

the

HPLC profile

for the

detritylated

oligonucleotide

5'-d(CGGTAATTACCG)-3'. All oligonucleotides purified using this system produced
identical HPLC retention times. Confirmation of peak identity was performed using
ESI-MS as outlined in Section 2.3 below. Figure 2.2 shows the ESI mass spectrum for
the detritylated oligonucleotide 5'-d(CGGTAATTACCG)-3'.
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Figure 2.2: ESI mass spectrum of the detritylated 5'-d(CGGTAATTACCG)-3'
oligonucleotide (where M is the oligonucleotide).

39

2. 2. Pyrindamycin A + Oligonucleotide Reaction
The pyrindamycin A used for this study was obtained from Dr Geoff Wickham of the
University of Wollongong.
The pyrindamycin A - oligonucleotide reactions were performed according to the
method of Boger and coworkers.(184) A solution of pyrindamycin A (1 mg in 0.5mL
DMF)

was

individually

added

to

both

5'-d(CGGTAATTACCG)-3'

and

5'-d(CGCGAATTCGCG)-3', in a 10:1 ratio, in 0.1 M sodium phosphate buffer (pH 7.4)
and stirred slowly, in the dark and at room temperature for varying reaction times from 2
hours to 14 days. HPLC purification was performed as for the oligonucleotides, only the
gradient was run over a period of 40 mins. Confirmation of peak identity was made
using ESI-MS as outlined in section 2.3 below.

2. 3. Mass Spectrometry
The majority of ESI mass spectra were acquired on a VG Quattro mass spectrometer
(VG Organic, Altrincham, UK) of quadrupole-hexapole-quadrupole configuration
equipped with an electrospray ionisation source which allowed mass analysis of singlycharged ions up to 4000 Da.

Nucleotide samples were dissolved in 50% aqueous

isopropanol (negative ion mode) or water (positive ion mode) at a concentration of 10
200 pmol pL \

An injection volume of 10 pL was used for each analysis. Samples

were introduced into the source by a flow of solvent delivered via an ISCO syringe
pump at 5-10pL min"1. A flow of warm, dry nitrogen (65°C, 1 atm) assisted evaporation
of the solvent. The electrospray probe tip potential was 3.5 kV, with 0.5 kV on the
chicane counter electrode. The mass range was calibrated using sodium iodide in the
positive ion mode and a standard sugar mixture was used for negative ions. Skimmer
potentials in the range 50-100V were used as indicated. Spectra were acquired at a rate
of 100 m/z per second and typically 10-15 scans were summed to obtain representative
spectra.
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2. 4. Tandem Mass Spectrometry (MS/MS)
Low-energy MS/MS spectra were acquired on the VG Quattro mass spectrometer. For
the MS/MS studies the collision gas used was argon and the collision energies ranged
from 10-70 eV. The resolution in MSI was set to a minimum and the resolution in MS2
was ~ 1.5 Da (peak width at half-height). The photomultiplier was 650 V.
High energy MS/MS spectra were acquired on a VG Autospec magnetic sectororthogonal acceleration (Mag-oa-TOF) mass spectrometer (VG Organic, Wythenshawe,
UK). Samples were approximately 200-400 pmol/pL in 50% aqueous acetonitrile or
50% aqueous isopropanol. The samples were continuously infused via a Harvard
Syringe pump at a flow rate of 10 pL min 1 or in the case of the pyrindamycin A reaction
products injected using a rheodyne 7125 injector. The collision gas was either methane
(5'-ApCpC-3') (5’-d(CGGTAATTACCG)-3’) and ((PyA-Cl) + base A) or xenon (5'd(AGGCCT)-3). The laboratory collision voltage was 400 eV for singly-charged ions
and 200 eV for multiply-charged ions.
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3. ESI-MS/MS

Small

Oligonucleotides
The initial work in this study involved characterisation of a large set of
dideoxyribonucleotide monophosphates (i.e.

d(AC), d(CA), TT, d(AT), TdA, TdG,

TdC, d(AG), d(AA), d(GG)) at a range of laboratory collision energies and skimmer
potentials.

As mentioned in chapter one, studies utilising FAB-MS/MS have been

performed on the complete set of dinucleotides.(148) It was of interest, therefore to
determine if the same fragmentation pathways were observed in ESI-MS/MS spectra of
the same compounds, since the initial internal energy of the ions was expected to be
lower in the case of ions generated by ESI compared to FAB.

3.1. Protonated Dinucleotides
Figure 3.1 shows the MS/MS spectra of the [M+H]+ ion of d(AC) obtained at a
laboratory collision energy of 40 eV and skimmer potentials of 30 V (Figure 3.1a) and
70 V (Figure 3.1b) respectively.

The skimmer potential determines the degree of

acceleration of the ions through the intermediate pressure region in the source such that
higher skimmer potentials generally increase the excitation of the ions and more
fragmentation results.(194) In this example, more abundant fragment ions are observed
when the higher skimmer potential was used, although the nature of the fragments is
unchanged. The most abundant ion in these spectra is at m/z 112 owing to loss of the 3'
base (cytosine) with charge retention and hydrogen transfer i.e. so-called BH2+ ions(43).
The peak owing to the BH2+ ion for adenine (m/z 136) is less intense. In Figure 3.1b
there are “pairs” of the BH2+ ions, which correspond to losses of neutral cytosine and
adenine, at m/z 430 and m/z 406 respectively. The ion at m/z 308 presumably arises
from cleavage of the 3'C-O bond in the sugar from which cytosine is lost (i.e. [wi+2H]
according to scheme 1.1). The remaining ions in the spectrum are due to the [PO3FE]
(m/z 81) or fragments of the phosphate and sugar residues (m/z 179, 197, 216).
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R elative Intensity
Figure 3.1: ESI-MS/MS spectra of the [M+H]+ ions of d(AC), with Eiab-40 eV and
skimmer potential of a) 30 V, and b) 70 V
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Further investigation by ESI-MS/MS of d(CA) and d(AG) showed results consistent
with those obtained for d(AC). Figure 3.2 a and b show the ESI-MS/MS mass spectrum
of the [M+H]+ ion of d(CA) using a laboratory collision energy of 50eV with a skimmer
potential of 40V and 80V respectively.

In these spectra, the most abundant ion at

m/z 332 was the [wi+2H]+ ion, closely followed by m/z 430, which is owing to the loss
of the 5' base from the molecular ion. Other ions observed in the spectra, m/z 136 and
m/z 112, corresponded to the BH2+ ions of the bases adenine and cytosine respectively.
Figure 3.3 a and b shows the ESI-MS/MS spectra for the [M+H]+ ion of d(AG) at a
laboratory collision energy of 50eV when the skimmer potential is at 40V and 80V
respectively. Both of these spectra are dominated by m/z 152 which is the BH2+ ion of
the 3' base, guanine. The ions observed at m/z 446 and 430 are the result of the loss of
each of the bases adenine and guanine respectively from the protonated molecular ion.
Ions due to the adenine (m/z 136), [P03H2]+ (m/z 81) and fragmentation of the
phosphate and sugar residues (m/z 216) were also observed.
Dominance of the BH2+ ion of the 3' base was found to be a general trend in the MS/MS
spectra of [M+H]+ ions of all the dinucleotides examined, except when the 3' base is
thymine, in which case the BH2+ ion of the 5' base was generally more intense and in
most cases no peak was observed for the thymine.

Figure 3.4 highlights these

observations using TT (Figure 3.4a), and d(AT) (Figure 3.4b). Figure 3.4c shows that
when thymine is the 5' base there is no deviation from the general trend.

These

observations are in accord with the earlier FAB-MS/MS study(148) in which it was
suggested that the lack of a BH2+ ion from 3' thymine can be understood in terms of
charge distribution in a model structure and the large difference in proton affinity of
thymine compared to the other bases.
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Figure 3.2: ESI-MS/MS spectra of the [M+H]+ ions of d(CA) with E|ab=50 eV and a
skimmer potential of a) 40 V, and b) 80 V

45

581 [M +H ]+

x 100-1

a)

R elative Intensity

%-

81

152
* 216

100

200

447
300

400

500

600

581 [M +H ]+

100-1

b)

%-

152
430
100

200

300

400

446

500

600

m/z

Figure 3.3: ESI-MS/MS spectra of the [M+H]+ ions of d(AG) with Eiab-50 eV and a
skimmer potential of a) 40 V, and b) 80 V
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The MS/MS results obtained in this study for the protonated molecular ion produced similar
fragmentation products to those obtained in experiments performed by Rodgers et al. (194a)
on a FTICR mass spectrometer. In both cases, the major fragment ion observed was the
BH2+ ion of the 3' base. Additional fragments were dinucleotide species dependant but
generally the same for the different mass spectrometers. Differences between the
instruments were only observed when the dinucleotide contained T.(194a) The proposed
reaction mechanism for the formation of the BH2+ fragment ion is shown in Scheme 3.1.
(194a)
Scheme 3.1: Reaction Mechanism for the Major Fragmentation Pathway of Protonated
Dinucleotides
CH2OH5 r

OH

OH

3.2. Deprotonated Dinucleotides
Figure 3.5 shows the MS/MS spectra of the [M-H]' ion of d(AC) at different skimmer
potentials. In this case, only one fragment, the B~ ion of adenine at m/z 134, is evident in
the spectrum obtained at the lower skimmer potential (30 V). Additional fragment ions
observed at the higher skimmer potential (70 V) are the B' ion of cytosine (m/z 110), the
cleavage of the ribose phosphate 3’C-O in the sugar from which cytosine is lost, (wf, at
m/z 306) and the ion resulting from loss of neutral adenine (m/z 404). There are also
peaks corresponding to the PCV phosphate group (m/z 79) and the phosphate plus the
sugar residue (m/z 195).
Figure 3.6 displays the ESI-MS/MS spectra for d(CA) using a laboratory collision
energy of 50eV and skimmer potentials of 20V and 80V. At the low skimmer potential,
no fragmentation is observed. In contrast, the spectrum obtained at the high skimmer
potential exhibits peaks at m/z 428 which is due to the loss of cytosine from the
deprotonated molecular ion, the w f ion at m/z 330, a f at m/z 210, and m/z 195, the
phosphate plus the sugar residue. The ions at m/z 134 and m/z 110 correspond to the B*
ions of adenine and cytosine respectively, with cytosine being the more intense of the
two.
Figure 3.7 shows the two ESI-MS/MS spectra obtained at a laboratory collision energy
of 50eV for d(AG) with skimmer potentials of 40V and 80V.

The only fragment

observed for the low skimmer potential is m/z 134, due to the 5' base adenine. In the
spectrum for the higher skimmer potential, the most intense peak (m/z 134) is the B* ion
of the 5' base adenine. The remaining ions in the spectrum are m/z 444, owing to the
loss of adenine from the molecular ion; the wi ion at m/z 346; m/z 195 arising from the
phosphate plus the sugar residue; and the m/z 79 ion owing to the P 0 3' group. This
example also demonstrates that at least qualitatively, the skimmer potential has a greater
influence on the MS/MS spectra of the deprotonated dinucleotides than on the
protonated species. This can be seen when comparing Figures 3.3a and 3.7a for dAG, in
which several peaks in addition to the BH2+ ions are observed for the protonated species,
whereas the deprotonated species showed only the B‘ ion.
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Figure 3.5: ESI-MS/MS spectra of the [M-H]' ions of d(AC) Eiab-40 eV skimmer
potential a) 30 V b) 70 V
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Figure 3.6: ESI-MS/MS spectra of the [M-H]" ions of d(CA) with Eiab-50 eV and a
skimmer potential of a) 20 V, and b) 80 V
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The MS/MS results obtained for the deprotonated dinucleotides in this study were found to
resemble those obtained by Rodgers et al. (194b) on a FTICR mass spectrometer. The major
product ions observed were independent of the dinucleotide species and the mass
spectrometer type. The major fragments observed were the 5' base B' ion and the fragment
resulting from the loss of the neutral 5' base from the molecular ion.(194b) The reaction
mechanism for the production of these two fragment ions is given in Scheme 3.2. (194b)
Scheme 3.2: Reaction Mechanism for the Major Fragmentation Pathway of Deprotonated
Dinucleotides

OH

In contrast to the spectra of the [M+H]+ ions, the dominant fragment ions in the spectra
of the [M-H]' ions arise from loss of the 5' base. This was found to be a general trend
for all the dinucleotides examined, including those containing thymine.

Thus the

MS/MS spectra of [M-H]' ions of dinucleotides appear to be more diagnostic of base
position than those of the [M+H]+ ions. This is also consistent with MS/MS studies of
[M-H]' ions following fast atom bombardment (FAB).(148) The spectra obtained at the
higher skimmer potentials are similar to the FAB MS/MS spectra of the same
dinucleotides. This supports the view that ions generated by FAB have higher initial
internal energies than following ESI.(195) As previously reported,(194) the MS/MS
spectra of deprotonated dinucleotides should have applications in determining the
sequence of modified dinucleotides that may be obtained following digestion of large
segments of DNA, in which the action of the nucleases is blocked by the modification.
These results demonstrate that MS/MS spectra of dinucleotides following ESI may be
equally as useful in this regard as the FAB-MS/MS spectra.

3.3. Cationised oligonucleotides
The MS/MS spectra of cationised adducts of dinucleotides were also examined in detail
in an attempt to see if these adducts yielded more information. When ESI-MS/MS was
performed on the [M+Na]+ adduct of TTT (Figure 3.8a) there was no significant increase
in fragmentation observed compared with the ESI-MS/MS of the [M+H]+ molecular ion
(Figure 3.8c). The spectra of the [M+K]+ ion (Figure 3.8b) yielded no fragment ions
even under relatively harsh collision conditions.
The ESI-MS/MS spectra of the [M+Li]+ adduct of the dinucleotides showed a greater
number of fragments compared to the corresponding [M+H]+ and [M-H]' ions. Figure
3.9a shows the MS/MS spectra of the [M+Li]+ ion of d(AC), and the corresponding
ribonucleotide ApC is shown in Figure 3.9b.

For d(AC), the sequence ion

[wi+H+Li]+(m/z 314) is the major fragment, rather than the BH2+ ions. There are also
ions such as [yi+H+Li]+(m/z 234), [dr 2H+Li]+, and fragments resulting from additional
cleavages of the sugar residue (m/z 204), none of which are present in the spectrum of
the [M+H]+ ions. This is not surprising, given that the Li attachment has previously
been shown to enhance the fragmentation of saccharides.(196)(197)
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Figure 3.8: ESI-MS/MS spectra of the TTT ions a) [M+Na]+ with Eiab-50 eV, b)
[M+K]+ with Eiab-100 eV, and c) [M+H]+ with Eiab=75 eV, with skimmer potential 65 V
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Figure 3.10: ESI-MS/MS spectra of the [M+H]+ ion of ApC with Eiab=50 eV and a
skimmer potential of 50 V
It is interesting to note that there are also several cases in which Li appears to have been
lost, with the neutral fragment resulting in protonated fragment ions, for example the
BH2+ ion of adenine and the ions at m/z 197 and m/z 216, which are fragments of the
phosphate and ribose. The MS/MS spectrum of the [M+Li]+ ion of the ribodinucleotide
monophosphate ApC (Figure 3.9b) shows intense peaks due to the loss of adenine (m/z
444), the BHLi+ ion of cytosine (m/z 118), the [wi+2H+Li]+ ion (m/z 331), and the
[yl+H+Li]+ ion (m/z 250). These two sequence ions were not present in the MS/MS
spectrum of the [M+H]+ ion of ApC (Figure 3.10) obtained under the same conditions.

3. 4. Larger Oligonucleotides
The MS/MS spectra of the [M-H]' and [M-2H]2*ions of the ribonucleotide ApCpC were
obtained on the triple quadrupole and are shown in Figure 3.11. Assignments of the
major fragment ions are given in Table 3.1. The spectrum of the doubly-charged ion
yielded a smaller number of fragments than the corresponding singly-charged ion.
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Figure 3.12 shows the MS/MS spectrum of the [M-H] ion obtained on the
magnetic sector-time-of-flight (mag-TOF) instrument for comparison with the spectrum
in Figure 3.1 lb. There are several additional fragment ions, and the signal-to-noise ratio
is superior in the spectrum obtained on the magnetic sector - TOF instrument, reflecting
both the higher collision energy available and the better sensitivity of the latter
instrument. In all cases, both sequence and base ions are observed. Using Scheme 1.1,
in which the oligonucleotide is shown as neutral, these are denoted as deprotonated
species.
Table 3.1. Assignments of Major Fragment Ions in MS/MS spectra of 5'-ApCpC-3'

FRAGMENT IONS m/z
[M-H][M-H][M-2H]2Elab= 400 eV
Elab = 50 eV
Elab = 50 eV
79
79
79
97
97
97
110
110
110
134
134
134
177
195
211
211
211
305
322
322
322
347
346
420
420
438
438
442
530
547
547/8
554
609
610
634
708
766
877
-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

—
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ASSIGNMENT
(refer to scheme 1.1)
p o 3h 2p o 4B2/3(C)B i (A)sugar + PO3
sugar + PO4H2
[di-Bi-H]-or [w i-B3 -H][XJ-H]Wj
di
[z2 -B2-H][y2-B2-H][a2-B2-3H]z2"
yi~
[a2-H][x2 -H][c2 -H]-

loss of B2/3 (C)
[M-H]'

134
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Figure 3.11: ESI-MS/MS of 5'-ApCpC-3' obtained on the triple quadruple for the
a) [M-2H]2’ ion with Eiab=50 eV and skimmer potential of 40 V, and the b) [M-H] ion
with Eiab=50 eV and skimmer potential of 65 V
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Figure 3.12: ESI-MS/MS spectrum of the [M-H]" ion of 5'-ApCpC-3' obtained on the
magnetic sector-time-of-flight instrument with the collision cell voltage=400 eV
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A limited number of larger oligonucleotides were also examined on both instruments.
Figure 3.13 shows the MS/MS spectrum of the [M-2H]2' of 5’-CACGTG-3’ obtained on
the triple quadrupole instrument with a laboratory collision energy of 40 eV and a
relatively high pressure (8 x lO'4 mbar) of argon collision gas. At lower pressures, only
the ions due to the base and the phosphate group are observed. Assignments of the
major fragments in the spectrum labelled according to the nomenclature shown in
Scheme 1.1 are given in Table 3.2.

m/z
Figure 3.13: ESI-MS/MS spectrum of the [M-2H]2' ion of 5'-d(CACGTG)-3' obtained
on the triple quadrupole Eiab=40 eV skimmer potential 55 V
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T a b le 3.2. Major Fragment Ions in MS/MS spectrum of 5' d(CACGTG)-3'

Observed m/z
Assignment
988
[a4-B4(G) -3H]979
W3895
[M-2H]2833
[M-B5(I)]2819
[M-B4/6(G)]2810
[M-B4/6(G)-less H20-H]2790
[w5-H]2771
[d5]2699
[a3-B3(C) -3H]"
650
W2"
632
[X2-H]616
[d2-3H]601
[c2-2H]506
[d2-B2(C)-3H]490
[w3-H]2466
[c2-B2(A)-3H]426
408
[a4-4H]2-

Observed m/z
386
346
329
312
303
288
257
230
195
177
159
150
134
125
110
97
79

Assignment
[a2-B2(A)-3H]Wj"
nucleotide** G
nucleotide** A
nucleotide** T
nucleotide** C
-

G + sugar (C5H7O)
[sugar (C5H7O2) + PO4H2]'
[sugar (C5H7O2) + P 0 3]*
[sugar (C5H7O2)+PO3-H20]*
[G][A][T]‘
[C]‘
h 2p o 4P 0 3-

Based solely on the masses, it appears that both singly- and doubly-charged fragments
are observed.

The base peak in the spectrum is the ion due to the deprotonated

phosphate group P03‘ (m/z 79), however there are also intense peaks characteristic of
the sequence. For example, there is almost a complete set of “w” ions (wi, W2, W3 and
W 5).

McLuckey et a l have reported this as a major fragmentation pathway in the

MS/MS spectra of multiply-charged oligonucleotide anions with a preference for base
loss in the order A > T » C > G.(l 53) The same strong preference for loss of adenine
is not observed here (in which case the W2 ion at m/z 650 would be expected to be the
major fragment). Initially it was not clear whether this was because of the different
collision conditions in the triple quadrupole compared to the ion trap, or whether the
difference arises from the lower charge state of the oligonucleotides examined.

"nucleotide refers to the base + the sugar + P 0 3H
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Barry et al have observed loss of all non-terminal bases for the triply-charged ions of
modified oligonucleotides with similar sequence (CACGXG) in MS/MS spectra
obtained on a triple quadrupole,(198) it is likely that the different collision conditions is
the important factor. Weimann et al.( 199) have also shown that the charge state is not
the dominant factor for determining the nature of the fragment ions in MS/MS spectra.
There are many other so-called sequence ions present in the spectrum. A number of the
ions which appear to result formally from transfer of one or more hydrogens to the
neutral fragment are consistent with those observed by Barry et al, who also reported
[cn-2H] ions.(198) The hydrogen transfer appears to be internally consistent, as there
are both W3_ and [W3 -H] ' ions present in the spectrum, the xn ions all have masses
corresponding to [xn-H]_, and the [dn-3H]_ series is also present. There have been
insufficient studies of oligonucleotide fragmentation to allow hydrogen transfer to be
predicted in the same way as can be done for peptides.

This is one aspect of

oligonucleotide fragmentation that needs to be examined in more detail in future studies.
A further difficulty with interpretation of the MS/MS spectra of multiply-charged ions is
the determination of the charge state of the fragment ions if all the complementary ions
are not observed. This problem has been approached by various groups in different
ways. If a high resolution MS/MS spectrum is available such as with Fourier transform
mass spectrometry (FT-MS), then charge states can be determined directly.(155) Barry
et al have used complementary ions containing sodium to determine the charge states in
the low resolution MS/MS spectra of oligonucleotides obtained on a triple
quadrupole.(198) In these experiments, a singly-charged parent ion was indicated by a
mass shift of 22 Da (22/1), doubly-charged by 11 Da (22/2), etc.

The

magnetic sector-time-of-flight combination has the potential to resolve some of the
possibilities based on peak widths.
Figure 3.14 shows the MS/MS spectrum of the [M-2H]2‘ ion of 5'-AGGCCT-3'
obtained on the mag-TOF instrument, and Table 3.3 gives the major fragment ions in the
spectrum.
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Table 3.3. Major Fragment Ions in the MS/MS spectrum of 5' d(AAGGCT)-3'
Observed m/z
895
778
739
641

Assignment
[M-2H]2’

610

W2 "
[34-2H]2-

592
508
408
368
346
329
321

Observed m/z
305
288
257

[ w 5 -H ]2 -

Y52'
[c2 -2H]2-

239
195

[dGp-H]nucleotide” G

177
150
134
125
110
96

wi"

79

[d2 -B2 (G)- H]-

-

Assignment
nucleotide” T
nucleotide” C
[y1 + OH-H][y l -2H]~
[sugar + P0 4 H2]‘
[sugar + P03]'
[Gj[A]’
[T]'
[C]h 2 po 4P03-

[M -2H ]2'

m/z
Figure 3.14: ESI-MS/MS spectrum of the [M-2H]2' ion of 5'-d(AGGCCT)-3' obtained
on the magnetic sector-time-of-flight instrument collision cell voltage= 2 0 0 eV

“ nucleotide refers to the base + the sugar + P 03H
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A number of sequence ions are observed in the spectrum which demonstrates that useful
MS/MS spectra can be generated under the collision conditions available on that
instrument. Hence it should be possible to extend this to a more detailed study of
fragmentation of doubly-charged oligonucleotide anions using the 13C-approach for
charge state determination.
Figure 3.15 shows the ESI-MS/MS spectrum for the [M-4H]4' ion of the oligonucleotide
5'-d(CGGTAATTACCG)-3' obtained on the mag-TOF instrument. Table 3.4 displays
the assignments of the fragment ions observed in that spectrum.
Table

3.4:

Fragment

ion

5'-d(CGGTAATTACCG)-3'

Observed m/z
910
886
882
876
872
861
857
794
785
775
719
715
674
635
514
506
490
481
408

assignments

for

the

[M-4H]4'

ion

of

‘

Observed m/z
383
368
346
328
312
303
288
230
216
201
195
177
159
150
134
125
110
97
79

Assignment
[M-4H]4'
[c,-B 9 (A)]3[b3-2H]' or [y6]2’

[z6]2' or [X9-B4(T)]3"
[c6-B6(A )f
[a9-B9(A )f
[y9-B4(T)]3[d8-B8(T ) f or [z8f
[c8-B8(T)]3‘ or [c5f
[x8 -B 5 (A)]3-

[w7]3' or [a3-B3(G)]‘
[c5 -B 5 (A)]2-

[a5-B5(A)]2[w2]‘ or [d2]'
[w5f
[X5] 3'

[x2 -B ii(C)-H2 0-H]'

[dr]2'
[d3-B3(G)]2- or

Assignment
[a4-H20-2H]3'
[w4 -B9 (A)]3-

[W|]' M
nucleotide G
nucleotide A
nucleotide T
nucleotide C
G + sugar ring (C5H7O)
A + sugar ring (C5H7O)
[b2-B2(G)f
[sugar + P 04H2]'
[sugar + P 0 3]’
[sugar + P 0 3- H20]"
[G]'
[A]’
[T]'
[C]'
H2P 04'
p o 3-

[w3 -B io(C)]2‘

386
A number of ions corresponding to sequence ions were observed. There were no ions
observed at m/z values higher than that for the [M-4H]4 molecular ion. The most
common series was that of the w ions for which approximately half of the ions were
observed. Difficulty was encountered while trying to assign the peaks because the ions
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could have been charged singly, doubly or triply. The assignments made here were
based on the most logical ions corresponding to those masses, however, ions such as m/z
719 could be assigned to either w73' or (a3 -B3(G))' for example. These results do show
that ESI-MS/MS on the mag-TOF is feasible for the study of quadruply charged parent
ions. In addition, the strong preference for loss of adenine is not observed as was also
the case for the [M-2H1 " ions of the two 6 -mers.

[M-4H]

Figure 3.15: ESI-MS/MS spectrum of the [M-4H]4" ion of 5'-d(CGGTAATTACCG)-3'
obtained on the magnetic sector-time-of-flight instrument collision cell voltage= 2 0 0 eV
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3. 5. Summary
In summary, this study has shown that at least for dinucleotides, more extensive
fragmentation (including those cleavages which result in sequence ions in large
oligonucleotides) is observed using higher skimmer potentials, as well as when
examining the MS/MS spectra of [M+Li]+ adducts. The use of Li needs to be explored
for larger oligonucleotides. In contrast to previous MS/MS spectra of oligonucleotide
anions obtained on an ion trap, a strong preference for loss of adenine is not observed in
the MS/MS spectra of hexamers obtained on either a triple quadrupole (Eiab = 40 eV) or
a magnetic sector time-of-flight instrument (Eiab=400 eV). Similarly, the [M-4H]4’ ion
of the 12 mer did not display a dominant loss of adenine, suggesting that differences in
collision energy between the ion trap and scanning instruments accounts for these
differences rather than the charge state of the precursor ion. Along with previous studies
of tandem mass spectra of oligonucleotide anions, the data presented here shows the
potential of MS/MS following electrospray ionisation for determining oligonucleotide
sequence, however this work has also highlighted the need for more detailed
investigations of the fragmentation of these anions (especially in relation to hydrogen
transfer between neutral and charged fragments and fragment ion pairs) before these
spectra are as readily interpretable as MS/MS spectra of peptides.
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4. Investigation of Pyrindamvcin A
Binding to DNA.
As noted in the introduction to this thesis (Section 1.5) pyrindamycin A (PyA) is an
antitumour agent known to alkylate adenine in DNA.

This chapter describes the

purification and the analysis of adducts of PyA and the oligonucleotides
5’-CGG TAA TTA CCG-3’ and 5’-CGC GAA TTC GCG-3’. These sequences have a
number of potential binding sites for pyrindamycin A.

5’-CGG TAA TTA CCG-3’

contains two potential binding sites, a high affinity site at A9 and a low affinity site at
A6.

The 5’-CGC GAA TTC GCG-3 sequence does not contain any of the highly

preferred binding sites, however binding to either of the two adenines may still occur.
The reaction conditions for PyA and the self complementary oligonucleotides are
described in Chapter two (Section 2.2).

4.1. ESI-MS and HPLC of Pyrindamycin A
In order to check the purity of PyA itself, and as a background to the studies on
PyA-oligonucleotide mixtures, the free PyA was analysed by ESI-MS in the negative ion
mode. Figure 4.1 shows the ESI mass spectrum for PyA. There are two peaks at m/z
506 and m/z 542 which correspond to [M-HC1-H]' and [M-H]' respectively, where M
represents PyA. There was also a peak at m/z 544 as expected owing to the [M-H]'
species containing one Cl isotope
Free PyA was also analysed by reverse phase HPLC under the same conditions used for
purification of the reaction mixtures (see Section 2.1) in order to determine the retention
time of PyA. The resulting HPLC profile, shown in Figure 4.2, indicates PyA elutes at
42 mins under these conditions.
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Figure 4.2: HPLC profile of Pyrindamycin A
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4. 2. Analysis of the Reaction Between PyA and
5’-CGG TAA TTA CCG-3’
The

binding

of

pyrindamycin

A

(PyA)

to

the

oligonucleotide

5’-CGG TAA TTA CCG-3’ was studied under a wide range of reaction conditions. A
HPLC profile of the PyA, 5’-CGG TAA TTA CCG-3’ reaction mixture following
incubation for

6

days is given in Figure 4.3. The major peaks were collected and

analysed by ESI-MS in the negative ion mode.
spectrum for the HPLC peak eluting at 26 mins.

Figure 4.4a shows the ESI mass
This was shown to be the free

oligonucleotide (referred to as M) with m/z 606 being [M-6 H]6', m/z 728 [M-5H]5' and
m/z 910 the [M-4H]4' ion. Figure 4.4b shows the ESI-MS spectrum acquired for the
HPLC peak eluting at 28 mins. This spectrum displayed peaks at m/z 701 and m/z 877
corresponding to the [M-A-5H]5' and [M-A-4H]4* molecular ions respectively, for the
oligonucleotide loss of adenine (A) species. Also seen in this mass spectrum is a peak at
m/z 641. This represents the [(PyA-HCl) + A]' adduct. That both of these species are
observed from a single HPLC peak suggests that these arise from decomposition of the
[M+(PyA-HCl)]‘ adduct (discussed in more detail in section 4.2.1). Figure 4.4c displays
the mass spectrum for the third HPLC peak which eluted at 36 mins. The main peak in
this spectrum is m/z 641 which corresponds to the [(PyA-HCl)+A]' adduct.

Figure 4.3: Typical HPLC profile for the PyA oligonucleotide reaction
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Figure 4.4: ESI mass spectrum for the HPLC fractions obtained at retention times of a)
27 mins, b) 29 mins, and c) 37 mins.
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4-

During all of the reactions of PyA with this oligonucleotide, the HPLC profile did not
display a peak corresponding to the free ligand. This was thought to be caused by some
of the ligand precipitating out of solution during the stirring of the reaction, following
loss of the dimethylformamide (DMF) which is necessary to dissolve PyA.
PyA absorbs well in the UV range because of its two benzene and three amino rings.
Even though free PyA is not observed in the HPLC and ESI mass spectrum, occasionally
hydrolysed PyA ((PyA-HCl) + H2 O) was present. The mass spectrum in Figure 4.5
shows the [M-H]'ion of hydrolysed PyA at m/z 524 and its dimer at m/z 1050.

[M-H]

4.2.1. C onfirm ation of Peak Identity
The identity of the [M-HC1+A-H]- (m/z 641) adduct was confirmed by MS/MS. This
spectrum is displayed in Figure 4.6. The main fragments observed were the peaks at m/z
134 and m/z 506 which are known from MS studies to correspond to the base A and
[PyA-HCl-H]’ ions respectively.

At present the identity of the (oligonucleotide-A)

species represented by the [M-5H]5' molecular ion (m/z 701) is only based on the
molecular mass since this peak was not sufficiently abundant for MS/MS analysis.
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Figure 4.6: MS/MS of [(PyA-HCl)+A]‘

4. 2. 2. Evidence

for

Decomposition

of

the

O ligonucleotide-PyA A dduct During ESI-MS
The ESI mass spectrum of the HPLC peak at 28 minutes (Figure 4.4b) did not show
evidence of an intact PyA-oligonucleotide adduct. This raised the question of whether
such an adduct was sufficiently stable in solution to be detected. Alternatively, if the
adduct is present in solution, was it decomposing during sample introduction or
ionisation? The latter explanation was thought to be more likely for several reasons.
Firstly, after reacting for approximately 3 days, the third peak eluting at 36 mins is
observed and corresponds to the [(PyA-HCl)+A] adduct alone, suggesting that when
this species is present in the original reaction mixture it is well resolved from other
species by the HPLC.
Secondly, if decomposition occurred in solution the (oligonucleotide-A) product would
contain an additional H2 O which has not been observed. Such products are observed
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with reactions between the alkylating agent hedamycin, which alkylates the N7 position
of guanine.(200)
The dependence of the (PyA-HCl + oligonucleotide) adduct formation on the reaction
conditions was studied using variations to the standard reaction method, in terms of the
reaction time, the pH, and the buffer used (which may have affected the final pH of the
reaction mixture and hence the stability of the adducts). Table 4.1 provides a summary
of the reactions studied. In this table the peak occurring at 28 mins is referred to as the
(PyA-HCl + oligonucleotide) adduct, despite the fact that in some cases only the
decomposition products are observed.
The table indicates the reaction conditions under which the (PyA + oligonucleotide)
adduct, the ((PyA-HCl) + A) adduct, and the (oligonucleotide-A) species were observed.
From the data given in the table it is then possible to determine the optimum reaction
conditions for the formation for each of the adduct species. The ((PyA-HCl) + A)
adduct and the (oligonucleotide-A) species were present under most of the reaction
conditions studied. The (PyA + oligonucleotide) adduct was not often seen, presumably
because of its dissociation into the other two species.
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Table 4.1: Summary of the reactions between pyrindamycin A and the oligonucleotides
BUFFER
SOLUTION
DMF
0.1M Na2 HP04
0.1M Na2HP0 4
0.1M Na2 HP04

pH

TIME

SPECIES OBSERVED
PyA+oligo 1 PyA+A | oligo-A
5’-CGG TAA TTA CCG-3’
1 ,6 , 8 days *
2,3,4 days *
~9
H, 1 , 1 ‘¿ ¿day*
9.01
V2 day+
1 day
X
X
1 V2 days
X
X
3 days #
6.95
V^lJV^day *
8.06
Vi day
X
X
1 day
X
X
1 Vi days *
3 days#
7.52
2 hours
X
4 hours
X
X
6 hours
X
X
V2 day
1 day#
X
X
1 V2 days
X
X
2 days
X
X
X
6 days
3 hours
7.82
X
X
5 hours
X
X
7 hours
X
X
V2 day
X
X
1 day
X
X
1 V2 days
X
X
2 days
X
X
X
6 days
X
X
X
3 days
7.79
X
X
X
7 days
X
X
X
9 days
X
X
X
1 1 days
X
X
v.sml pk
1 0 days
7.96
5'-CGC GAA TTC GCG-3'
X
X
X
3 days
8.1
X
7 days
X
X
1 0 days
-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.1MNH4 OAc
O.IMNH4 HCO3

0.1MNa2 HPO4

-

-

-

-

0.1M Na2 HP04

-

0.1M Na2 HP0 4

0.1M Na2 HP04
0.1MNa2HPO4
Dickerson
sequence

-

X species present as determined by ESI-MS. For more explanation see text
* Only free oligonucleotide observed
+ HPLC had some problems but appears to be the same as for day 1.
• N o ESI-MS confirmation but HPLC appears to be the same as for day 1.
# N o ESI-MS confirmation but HPLC appears to be the same as for day 1Vi.
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1/
Three different buffers, 0.1 M Na)PC>4 with pH 9.01, 0.1 M NH4 OAC (pH 6.95), and
0.1 M NH4 HCO3 (pH 8.06), were also trialed. Reactions of PyA reported in previous
studies used 0.1 M Na2 PC>4 . The two ammonium buffers were assessed as they were
thought to be better for subsequent mass spectrometry analysis, because they do not
contain sodium. From Table 4.1 and the HPLC profiles in Figure 4.7, 4.8, and 4.9, it
was shown that the best results were obtained for Na2 PC>4 and NH4 HCO3 . This might be
a consequence of the lower buffering capacity of NH4OAc such that variations in the
final pH of the reaction mixture affect the final stability of the adducts. Therefore, to
H
overcome the potential problem of sodium contamination with the Na2 PC>4 buffer, HPLC
purification and on-line desalting on the mass spectrometer were used.

Figure 4.7: HPLC profile obtained using Na£P04 to buffer the reaction between PyA and
the oligonucleotide 5’-CGG TAA TTA CCG-3’, pH 9.01
Note that these and subsequent HPLCS in Fig. 4.7, 4.8 and 4.9 were run using different
buffers to that of Fig. 4.3.
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Figure 4.8: HPLC profile obtained using NH4 OAC to buffer the reaction between PyA
and the oligonucleotide 5’-CGG TAA TTA CCG-3’, pH 6.95

Figure 4.9: HPLC profile obtained using NH4 HCO3 to buffer the reaction between PyA
and the oligonucleotide 5’-CGG TAA TTA CCG-3’, pH 8.06

75

By varying the reaction time and keeping the buffer (Na2 HP04) and the pH (7.80)
constant, the number of species observed in the HPLC profile was increased. Figure
4.10 shows the amount of each of the two reaction products, relative to the unreacted
oligonucleotide over a period of time, from the HPLC profile. Note that this is only an
arbitrary measure since the UV extinction coefficients for the oligonucleotide and adduct
will be different.

Reaction Time (days)

Figure 4.10: Ratio of the relative peak heights of (oligonucleotide+(PyA-Cl)) (peak 2)
and ((PyA-Cl)+A) (peak 3) to unreacted oligonucleotide with time
From the data in this graph it was concluded that the (oligonucleotide + PyA) adduct
(the 2nd peak in the HPLC profile) reaches its maximum intensity after 2 days and stays
at relatively the same value after that.

The third peak owing to primarily the

((PyA-Cl) + base A) appears after 2 days but was not present in sufficient concentrations
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until day 6 to be analysed by ESI-MS. This peak was never observed to be greater than
the second HPLC peak.
Table 4.2 shows the adducts observed for each reaction buffered by Na2 HPÛ4 . From the
data shown in this table it can be observed that when only two peaks are present (one
being the free oligonucleotide) only ions corresponding to the (oligonucleotide-base A)
and ((PyA-Cl)+A) species are observed in the ESI mass spectrum for the second peak.
As time progresses, on average after about 6 days, a third peak is observed. This peak
contained ((PyA-Cl)+A) (641 m/z) and the second peak contained some (oligonucleotide
+ (PyA-Cl)) and (oligonucleotide-A) (701 m/z).

The optimum reaction time for

observing the (oligonucleotide + (PyA-Cl)) adduct is after 9 days. However, to observe
the other two species 1Vi -2 days is sufficient.
Table 4.2: Presence of Adducts using the Na2 HPÛ4 buffer

PH

time
PyA + oligo

9.01

1 day

7.96

1Vi days
4 hours
6 hours
lA day
1 day
1Vi days
6 days
5 hours
7 hours
Vi day
1 day
1y2 days
2 days
6 days
3 days
7 days
9 days
11 days
10 days

8.1

3 days

7.52

7.82

7.79

Dickerson
sequence
used

7 days
(run for lhr)
10 days

Presence of Adduct
oligonucleotide - A
PyA -Cl + A
19 mins
18 mins

-

-

-

-

-

-

-

-

in 29 min peak
-

-

-

-

in 28 min peak
17 mins
12 mins
17.5 mins
20 mins
17.5 mins
21.5 mins
21 mins
23 mins
also25&28mins
36 mins
55 mins
24 mins
in 35 mins peak
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25 mins
26 mins
28 mins
27 mins
37 mins
26.5 mins
26 mins
28 mins
25 mins
27 mins
29 mins
36 mins
all species
all species
all species
in 20 min peak
18.5 mins vsml
21.5 mins
25 mins
28 mins
-

35 mins

unresolved from PyA+A
unresolved from PyA+A
27 mins
unresolved from PyA+A
unresolved from PyA+A
unresolved from PyA+A
unresolved from PyA+A
29 mins
unresolved from PyA+A
unresolved from PyA+A
unresolved from PyA+A
unresolved from PyA+A
unresolved fromPyA+A
unresolved from PyA+A
28 mins
unresolved
unresolved
unresolved
32 mins
17.5 mins v.sml
18.5 mins
in 21 mins peak v.sml
in 25 mins peak v.sml

Figure 4.11, 4.12, and 4.13 show the effect of pH on the HPLC profile when the reaction
time was kept constant at 114 days. The reactions were performed at pH 7.52, 7.82, and
9.01 respectively. Of the three different reaction pH’s studied, pH 9.01 was observed to
produce the greatest ratio of free oligonucleotide to (oligonucleotide + (PyA - Cl)). This
may result from the higher pH increasing the rate of the reaction, due to the phenolic
hydroxyl being first converted into a C=0 group in order for the alkylation of adenine to
take place. This conversion is favoured at high pH. ESI-MS of these HPLC peaks does
not show the (oligonucleotide + (PyA - Cl)) adduct presumably because it is
decomposed to ((PyA-HCl) + A) and (oligonucleotide - A) during the ionisation process.

Figure 4.11: HPLC profile for the reaction between PyA and the oligonucleotide
5’-CGG TAA TTA CCG-3’ performed at pH 7.52
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35

Figure 4.12: HPLC profile for the reaction between PyA and the oligonucleotide
5’-CGG TAA TTA CCG-3’performed at pH 7.82

Figure 4.13: HPLC profile for the reaction between PyA and the oligonucleotide
5’-CGG TAA TTA CCG-3’ performed at pH 9.01
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4. 2. 3. O ptim isation of HPLC Purification
In order to determine if the PyA + oligonucleotide adduct was being formed but not
resolved from the free oligonucleotide, the gradient used for the HPLC purification was
varied. The usual gradient was a linear run from 0 to 100% of 60% aqueous acetonitrile
in 0.1 M NH4OAC over 40 mins. This gave rise to the HPLC profile shown in Figure
4.14. When the gradient was run slowly to approximately 45% of the total time and then
fast for the remainder of time, the HPLC profile shown in Figure 4.15 resulted. From
these two profiles it can be seen that a slightly better separation is obtained for the
nonlinear gradient. This difference was not, however, sufficient to warrant its use for all
of the subsequent reactions.

Figure 4.14: HPLC profile using the linear gradient
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Figure 4.15: HPLC profile using the non-linear gradient

4. 2. 4. Summary
In summary, from the ESI mass spectra and the HPLC profiles it can be concluded that
the best conditions for the observation by ESI-MS of the (oligonucleotide + (PyA-Cl))
adduct were 11 days at pH 7.8.

The best conditions for observation of the

((PyA-HCl)+A) adduct were 10 days with pH 7.96, and for the (oligonucleotide - A)
species were 3 days and pH 7.79. As only one HPLC fraction contained species relating
to the alkylated oligonucleotide, alkylation presumably only occurred at one site
indicating that the alkylation is very specific for this sequence. The most likely position
for this alkylation was at A9 as this is a high affinity alkyaltion site (refer Section 1.5.1),
however, further MS/MS experiments to confirm this were limited by the lability of the
adduct.
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4.3. Analysis of the Reaction Between PyA and
5’CGCGAATTCGCG-3’
The pyrindamycin A reaction with the oligonucleotide sequence known as the Dickerson
sequence, 5'-CGC GAA TTC GCG-3', was also examined.

Figure 4.16 shows the

HPLC profile for this reaction after 9 days. From the ESI mass spectra for this reaction
and the data given in Table 4.1, the (oligonucleotide + (PyA - Cl)) adduct is more readily
apparent by ESI-MS than the previous sequence. From the HPLC profile in Figure 4.16
four main peaks were observed. ESI-MS confirmed that the peak eluting at 16 mins is
free oligonucleotide.

The peaks eluting at 18 and 24 mins both contain the

decomposition products of (oligonucleotide + (PyA - Cl)), (oligonucleotide - A) and
((PyA-HCl) + A), and some of the intact adduct. The presence of the two peaks
containing the (oligonucleotide + (PyA - Cl)) adduct are evidence for alkylation at more
than one site in the DNA sequence. Thus the adducts have different retention times
owing to different steric influences but the molecular mass is the same. This might be
expected because the Dickerson sequence does not contain adenine in any of the
preferred binding sites, so alkylation is less specific. The final peak eluting at 35 mins is
due to the hydrolysed form of PyA. The ESI mass spectra shows a peak at m/z 525 for
the molecular ion of ((PyA-Cl)+H20) and a dimer is also observed at m/z 1050 (as was
the case in Figure 4.5). A peak was also observed at a retention time of 29mins,
howevei; it was not present in a high enough concentration for mass spectral analysis.
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Figure 4.16: HPLC profile for the reaction of PyA with the 5'-CGC GAA TTC GCG-3'
oligonucleotide
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5. Conclusion
This study has shown that for dinucleotides, more extensive fragmentation (including
those cleavages which result in sequence ions in large oligonucleotides) is observed
using higher skimmer potentials, or when examining MS/MS spectra of [M+Li]+
adducts. The [M+Na]+ and [M+K]+ adducts were also investigated by ESI-MS/MS.
These did not exhibit significantly increased fragmentation compared with [M+H]+
adducts. No fragmentation of the [M+K]+ ions were observed, and MS/MS of the
[M+Na]+ ion only produced a slight increase in fragmentation compared to the [M+H]+
ion when very harsh collision conditions were used.
The [M+H]+ spectra of dinucleotides were generally dominated by the BH2+ ion of the 3'
terminal base except when that base was thymine. In this case, no BH2+ ion was
observed, presumably because thymine has a very low proton affinity. The ESI-MS/MS
spectra of [M-H]' ions of the dinucleotides were dominated by the B‘ ion of the 5' base.
No exceptions to this trend were observed. This preferred loss of the 5' base to the 3'
base in negative ions becomes less significant for larger oligonucleotides so it cannot be
used for these molecules to assign the 5' base.
In contrast to previous MS/MS spectra of oligonucleotide anions obtained on an ion trap,
a strong preference for the loss of adenine is not observed in the MS/MS spectra of
hexamers, or for the 12 mer, obtained on either a triple quadrupole (Eiab=40 eV) or a
magnetic sector time-of-flight instrument (Elab=400 eV). The MS/MS spectra for the
12 mer provides a great deal of sequence information owing to cleavage of the
oligonucleotide backbone.

The w series is predominant for this sequence with

approximately half of this series being observed. The whole sequence may not be able
to be determined from the fragmentation, however confirmation of most of the sequence
can be achieved.

This is true also for the two hexamers for which the w series

predominates but again only half to two thirds of the ions in the series were observed.
Along with previous studies of tandem mass spectra of oligonucleotide anions, the data
presented here shows the potential of MS/MS following electrospray ionisation for
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determining oligonucleotide sequence, however this work has also highlighted the need
for more detailed investigations of the fragmentation of these anions (especially in
relation to hydrogen transfer between neutral and charged fragments and fragment ion
pairs) before these spectra are as readily interpretable as MS/MS spectra of peptides.
The reaction of the alkylating agent pyrindamycin A (PyA) with the oligonucleotides
5'-CGGTAATTACCG-3' and 5'-CGCGAATTCGCG-3' was studied by reverse phase
HPLC followed by electrospray ionisation mass spectrometry (ESI-MS). The intact
[M+(PyA-HCl)]‘ adduct (where M is the oligonucleotide) was not often observed by
ESI-MS but was observed as two decomposition products, the [(PyA-HCl)+A]‘ adduct
and the [oligonucleotide-AH]' species. This was assumed to be because this adduct is
particularly labile and thereby decomposes during ionisation.

From the ESI mass

spectral data and the HPLC profiles, it can be concluded that the best conditions for the
observation of the [M+(PyA-HCl)]' adduct was after 11 days at pH 8.0. As only one
HPLC fraction contained the species relating to the alkylated 5'-CGGTAATTACCG-3'
oligonucleotide, alkylation presumably only occurred at one site, most likely ATTA,
indicating that the alkylation is very specific for this sequence. ESI-MS/MS confirmed
that m/z 641 was the [(PyA-HCl)+A]‘ adduct, as fragments were observed for the
adenine m/z 134 and the [PyA-HCl]' m/z 506. The other decomposition product the
[M-AH]' species has only at this stage been postulated on the basis of molecular weight.
The HPLC profile for the 5'-CGCGAATTCGCG-3' reaction with pyrindamycin A was
shown to be nonspecific, as two HPLC peaks were observed for the adduct. This might
be expected as this sequence does not contain any preferential binding sites.
The data presented here for the interaction of the antitumour agent pyrindamycin A with
the oligonucleotides 5'-CGGTAATTACCG-3' and 5'-CGCGAATTCGCG-3' shows that
ESI-MS is feasible for characterising the resulting adducts. Initial studies that were
performed utilising ESI-MS/MS to obtain structural information of the adducts appears
to be very promising, however the stability of the resulting adducts can be a limiting
factor in some cases.
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